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CityWide Drugs Crisis Campaign hosted a conference in May of this year addressing the issue of 
drug-related crime and intimidation. Over 80 people attended the half-day event in Ballybough 
Community Centre in Dublin’s north inner city. The conference followed an event in October 2010 
at which CityWide hosted a meeting titled: ‘A community drug problem: defi ning the problem 
– defending the responses’, where the issue of intimidation emerged as a central issue for many 
communities throughout Dublin.1
In 2009 the Family Support Network (FSN)2 published the fi ndings of research into the issue of 
intimidation of the families of drug users by those involved in drug dealing.3 Through its work, 
the FSN became aware of a large number of families experiencing intimidation as a result of a 
family member’s drug-related debts. The intimidation of drug users and their families has also 
been highlighted as a key issue in the National Drugs Strategy 2009–2016 (NDS).4 Action 5 of the 
NDS aims ‘To develop a framework to provide an appropriate response to the issue of drug related 
intimidation in the community.’ 
The CityWide conference began with four short presentations. Detective Superintendent Michael 
O’Sullivan of the Garda National Drugs Unit reported on a pilot project in the Dublin Metropolitan 
Region. Established in March for a six-month trial period, the pilot works closely with the Family 
Support Network, and is designed to provide families and the wider community with a point of 
contact with the Garda Síochána. The project is to be reviewed at the end of August and, following 
feedback from stakeholders, is to be rolled out nationally. 
Graham Ryall, a community activist in the Canal Communities in Dublin’s south inner city, set the 
current issues against the historical backdrop of the 1980s and 1990s when anti-drugs groups 
such as the Concerned Parents Against Drugs (CPAD) emerged throughout the city to tackle drug 
dealing. In recent years, a partnership approach in Dolphin House involving the gardaí and local 
residents managed to put an end temporarily to open drug dealing. However, the economic 
downturn and the ‘shelving of plans’ to regenerate Dolphin House has, according to Ryall, ‘had a 
major negative impact on the community’.
Pictured at the CityWide conference: Mel MacGiobúin of the North Inner City Drugs Task Force 
and Independent TD Maureen O’Sullivan 
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CityWide conference  (continued)
The third speaker, Audra Cotter of the Clonmel 
Community Based Drugs Initiative in Tipperary, 
reported on an inter-agency initiative which 
has been positively evaluated and which is 
currently being rolled out across the south 
east region. Prior to this initiative, families who 
needed advice or direction from the gardaí 
were reluctant to attend the local Garda station 
for a number of reasons, including the lack of 
consistency in the Garda personnel they would 
encounter. Now, families can meet specifi c 
gardaí from the Community Policing Unit in 
venues in which they feel safe and comfortable. 
Johnny Connolly of the HRB highlighted the 
limited knowledge base in this area and the 
general failure of research and other information 
sources historically to properly refl ect the local 
impact of drug-related crime and intimidation 
on the individuals, families and communities 
most affected. He cited a recent Limerick study 
to illustrate the way in which gangs can employ 
a variety of strategies, from serious violence to 
verbal abuse and vandalism by young children, 
to instill fear and impose territorial control on 
communities.5 In terms of building sustainable 
responses, the potential of community-based 
mediation and the further enhancement of Joint 
Policing Committees were highlighted.
The fi nal part of the conference was dedicated 
to workshops where participants addressed the 
following three questions:
• What is the level of intimidation in your 
community?
• How has your community responded to 
the issue of intimidation so far? 
• What actions need to be taken?
The level and types of intimidation reported 
ranged from graffi ti and low-level harassment 
directed at vulnerable people to the killing 
of family pets, beatings, stabbings, hostage 
taking, the petrol bombing of people’s homes, 
threats of and actual sexual violence, shootings 
and murder. Threats of violence come from 
money lenders as well as from drug dealers. 
Gang members were known to wait outside 
post offi ces and dole offi ces to collect money 
from dependent drug users. Individuals also 
reported being forced to smuggle drugs into 
prison as part payment of a drug debt. Although 
many people turned to credit unions to pay 
drug debts, it was reported that many credit 
unions are now refusing to provide loans in such 
circumstances.
Single mothers living alone were particularly 
vulnerable; having to store or smuggle drugs 
as payment for a child’s drug debt contributed 
to high stress levels, leading to illness and 
depression. In such circumstances, the growing 
dependence of such people on prescription 
drugs exposes an ironic connection between 
illicit and licit drug markets. A rise in suicides 
by those in debt was also reported, although 
the debt does not die with the person. Another 
ominous development was the disruption of 
local drug projects, either through graffi ti or 
with gang members loitering outside projects to 
intimidate drug workers and clients. Outreach 
and healthcare workers reported being unable 
to enter certain areas because of control exerted 
by individuals or gangs.
With regard to community responses, all areas 
represented at the conference reported a 
reluctance to report incidents to the gardaí due 
to fear of reprisals. One immediate consequence 
of this is that the true levels of intimidation 
are not offi cially recorded anywhere. Where 
people did make formal complaints, it was felt 
that a promise of full Garda protection was not 
forthcoming. Community policing fora, where 
they existed, did help to build trust between 
the Garda Síochána and the local community. 
Also, an increase in Garda presence on the 
ground was reported as having a positive effect, 
although it could not be sustained over the 
long term. Similarly, CCTV had limited or no 
impact, as footage captured on cameras was 
reportedly not regularly monitored. Where it 
was monitored, the issue appeared to be simply 
displaced elsewhere.
A recurring theme related to drug-related 
intimidation within the Traveller community. The 
close-knit and isolated nature of the community 
meant that issues were seldom if ever reported 
to the gardaí. Where Travellers did report to 
the gardaí, other minor issues such as road tax 
were sometimes raised with the complainant, 
leaving them reluctant to engage further with 
the gardaí.
Services also face diffi culties working with 
young people who are themselves involved in 
intimidating others, as some will arrive in to 
services in bullet-proof vests and carrying guns. 
On the other hand, a great deal of positive 
youth work was reported at the conference, 
including efforts to encourage problematic 
youth into facilities and exploring perceptions of 
crime among young people. Another initiative 
involved young people working with senior 
citizens, teaching them how to use computers, 
for example. A local area partnership initiative 
involved attempts to promote a positive sense of 
community in response to anti-social behavior. 
Despite these positive examples, in general, 
most delegates at the conference reported a 
sense of frustration at the absence of effective 
responses to the serious issues being confronted. 
With regard to possible future approaches, a 
range of ideas was discussed, including: 
• More secure ways of reporting problems 
and more protection for those reporting.
• A ‘Dial to Stop Intimidation’ service, to 
be promoted as a community-based 
campaign, taking the emphasis away 
from Garda involvement so as not to 
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could also assist service users to make reports using 
this mechanism.
• An evidence base of incidences of intimidation, 
initially to be compiled informally at local level. 
• More resources into early interventions and youth 
development work.
• Joint Policing Committees be made more effective 
and accountable. 
• The court system to fast track intimidation charges 
and to ensure that evidence could be given safely.
• Community-based mediation, and community 
representatives to mediate safety issues with 
drug dealers.
• A national conference/national day on intimidation 
to highlight the issue and create unity among 
communities.
It was agreed that the Citywide Drugs Crisis Campaign 
would facilitate the establishment of an Intimidation 
Working Group comprising specialists from various agencies 
and representatives from the community and voluntary 
sector. The full conference report is available on CityWide’s 
website at www.citywide.ie.
(Johnny Connolly)
1. Connolly J (2010) CityWide conference discusses drug-
related intimidation. Drugnet Ireland, (36): 24.
2. The FSN was established in 2000 to support the 
development of family support groups throughout 
Ireland. There are currently over 70 family support 
groups affi liated to the FSN.
3. O'Leary M (2009) Intimidation of families. Dublin: Family 
Support Network. Available at www.drugsandalcohol.
ie/12898. See also Connolly J (2010) Drug-related 
intimidation of drug users and their families. Drugnet 
Ireland, (33): 18.
4. Department of Community, Rural and Gaeltacht Affairs 
(2009) National Drugs Strategy (interim) 2009–2016. 
Dublin: Department of Community, Rural and Gaeltacht 
Affairs.
5. Hourigan N (ed.) Understanding Limerick: social exclusion 
and change. Cork: Cork University Press.
CityWide conference  (continued)
National drugs strategy goes to 
Department of Health
Transfer of functions from the Department of Community, Equality and Gaeltacht Affairs 
With effect from 1 May 2011, the functions of the disbanded Department of Community, Equality and Gaeltacht Affairs 
transferred to other reconfi gured Departments. The table below sets out the functions relevant to the drugs issue and the 
Departments to which they have transferred. 
Function Department responsible Website
Community and rural development (including 
PEACE and INTERREG, dormant accounts and the 
Western Development Commission)
Department of the Environment, Community and 
Local Government
www.environ.ie
Co-ordination of the National Drugs Strategy Department of Health www.dohc.ie
Equality, human rights, integration and disability Department of Justice and Equality (these functions 
transferred with effect from 1 April 2011)
www.justice.ie
Charities regulation Department of Justice and Equality www.justice.ie
Social inclusion Department of Social Protection www.welfare.ie
Family policy Department of Children and Youth Affairs www.omc.gov.ie
Taken from a notice posted on the home page of the Department of Community, Equality and Gaeltacht Affairs 
(www.pobail.ie) on 11 May 2011
New units in the Department of Health
The functions relating to the co-ordination of the National 
Drugs Strategy have been assigned to two new units created 
in the Department of Health. 
Drugs Programme Unit 
The main function of this unit is to manage the Drugs 
Initiatives Programmes, which are primarily drug-related 
projects and initiatives in drugs task force areas. 
Drugs Policy Unit 
The main function of this unit is to oversee the 
implementation of the National Drugs Strategy 2009–2016 
through the fi ve pillars of supply reduction, prevention, 
treatment, rehabilitation and research. 
These new units can be contacted by email at 
dpu@health.gov.ie
drugnet 
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The National Advisory Committee on Drugs (NACD) now 
also comes within the remit of the Department of Health. Its 
main function is to advise the minister and the government 
in relation to the prevalence, prevention, treatment and 
consequences of drugs misuse. It also conducts and 
commissions research in relation to drug misuse. 
Co-ordination of drugs policy 
On 31 May 2011 Roisín Shortall 
TD, the Minister of State at 
the Department of Health with 
responsibility for Primary Care, 
with lead responsibility for the 
National Drugs Strategy 2009–
2016, responded to questions 
put to the Minister for Health in 
Dáil Éireann with regard to how 
drug policy will be co-ordinated 
at ministerial and departmental 
level.1 She and the Minister for 
Health, James Reilly TD, will both 
have roles – the Minister at Cabinet level, the Minister of 
State at Cabinet Committee level. While confi rming that the 
Oversight Forum on Drugs (OFD) and the Drugs Advisory 
Group (DAG), established under the National Drugs Strategy, 
will both continue, she went on to talk solely about an 
‘oversight committee’, the quarterly meetings of which she 
will chair, which indicates that she is referring to the OFD.
The NDS is a cross cutting area of public policy and 
service delivery and it is based on a co-ordinated 
approach across many Departments and agencies 
in conjunction with the community and voluntary 
sectors. The institutional arrangements to support 
cross agency working, advise on operational and 
policy matters, assess progress across the strategy 
and address any operational diffi culties include the 
drugs advisory group and the oversight forum on 
drugs. I intend that the work of these bodies will 
continue, …
With regard to implementation of the strategy, 
there is an oversight committee, which I will chair, 
and that will continue to meet on a quarterly basis 
and identify any logjams, diffi culties or delays in 
implementing the strategy. We are, therefore, serious 
about ensuring it is implemented in full. In addition, 
the Minister will be responsible for this issue at 
Cabinet level and it will continue to have a voice at 
the Cabinet table. The Cabinet sub-committee on 
social exclusion will deal with this issue as well and 
many of the offi cials involved in the oversight will 
feed into the sub-committee. It will receive attention 
there and the sub-committee will meet later this 
week. I will attend that meeting and I will be a voice 
in respect of the NDS. … 
The purpose of the oversight committee is to 
address issues such as crystal meth and other 
developments relating to illegal drugs. All the 
relevant bodies are represented at a senior level and 
one of the committee’s functions is to update all 
the members on current trends in respect of drug 
misuse. I give an assurance that all of the relevant 
agencies are represented at a senior level. I will 
convene the fi rst meeting of the oversight committee 
in the coming weeks. 
(Brigid Pike and Mairea Nelson)
1. Shortall R (2011, 31 May) Parliamentary Debates Dáil 
Éireann (Offi cial report: unrevised). Priority questions. Vol. 
733, No. 4, p. 10. National Drugs Strategy. Question 42. 
http://debates.oireachtas.ie/dail/2011/05/31/00010.asp
Programme for Government 2011–2016: 
measures that may impact indirectly on 
the drugs issue
In the last issue of Drugnet Ireland, the directly drug-related 
measures contained in the new Programme for Government 
were outlined.1 Other measures included under the broad 
heading of Fairness in the new Programme, which may 
be expected to impact indirectly on the drugs issue, are 
noted below.2
Health and mental health
The proposed Universal Health Insurance (UHI) will 
guarantee equal access to care for all, in both the 
primary care and the hospital systems. There will be no 
discrimination on the grounds of income or insurance status: 
in line with the European principle of social solidarity, access 
will be according to need and payment will be according to 
ability to pay. 
The government intends to establish an Integrated Care 
Agency to oversee the fl ow of resources between the 
different arms of the health system, in order to incentivise 
the provision of care in the best setting. 
With regard to mental health, the government endorses 
the recommendations contained in A vision for change. 
Ring-fenced funding will be provided to recruit additional 
psychologists and counsellors to community mental health 
teams, working closely with primary care teams to ensure 
early intervention, reduce the stigma associated with mental 
illness and detect and treat people who are at risk of suicide.
Education
The government states that ‘education is at the heart of a 
more cohesive, more equal and more successful society’. As 
resources allow, it will invest in a targeted early childhood 
education programme for disadvantaged children, building 
on existing targeted pre-school supports for families most in 
need of assistance such as the Ballymun Youth Action project. 
Roisín Shortall TD, 
Minister of State 
at the Department 
of Health 
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review of DEIS, the government will use DEIS as the platform 
for new initiatives to deliver better outcomes for students 
in disadvantaged areas. It will also examine how to make 
existing expenditure on educational disadvantage more 
effective, and innovative ways in which teenagers at risk of 
leaving the school system may stay connected, for example 
through use of ICT-based distance learning and projects such 
as iScoil.
Housing
Believing that prevention is better than cure, the 
government pledges to aggressively target the root causes 
of homelessness. By having a dedicated body to co-ordinate 
policy across government, it will target initiatives across 
departmental domains that will help to prevent problems 
like homelessness. The government is also committed to 
ending long-term homelessness and the need to sleep 
rough. It intends to review and update the existing Homeless 
Strategy, including a specifi c focus on youth homelessness. 
It endorses the ‘housing fi rst’ approach, fi rst championed 
in Ireland by the Homeless Agency in Dublin. Finally, the 
government is committed to urban regeneration to revitalise 
communities in areas such as Limerick in order to give 
families a better quality of life.
Justice and law reform
Anti-social behaviour, viewed as ‘so destructive of 
community life’, will be tackled through strengthening 
existing interventions such as community policing 
partnerships and forums, community policing, and 
alternative programmes for juvenile offenders such as the 
Juvenile Liaison Offi cer Scheme, the Garda Juvenile Diversion 
Programme, and the use of restorative justice measures. A 
12-month probationary period will be imposed on all new 
tenants public or social housing, and where tenants engage 
in anti-social behaviour during this probationary period, 
the tenancy will be terminated. The government also plans 
to examine outcomes-based contracts with community 
organisations to help reduce reoffending by young people, 
based on the social impact bond model in the UK.
The prison inspectorate is to be strengthened. The offi ce of 
the Inspector of Prisons will be put on a statutory footing. 
The Inspector of Prisons will make an annual report to the 
Minister for Justice and the Oireachtas Justice Committee, 
and will be empowered to appear before that Committee on 
such other occasions as may be appropriate. Prison visiting 
committees will furnish their reports to the Inspector of 
Prisons who will be under an obligation to publish them.
Equality and social protection
Reiterating the principle of social solidarity, already 
mentioned in relation to health, the government pledges to 
tackle Ireland’s economic crisis in a fair and balanced way. 
It lists a raft of measures to tackle poverty and protect the 
most vulnerable in society including those on social welfare 
benefi ts, the low paid, and the self-employed. With regard to 
child poverty, the government will ‘adopt a new area based 
approach to child poverty, which draws on best international 
practice and existing services to tackle every aspect of child 
poverty. Initially, this model will be rolled out to up to ten of 
Ireland’s most disadvantaged communities, in cooperation 
with philanthropic partners. 
(Compiled by Brigid Pike)
1. Connolly J, Pike B, Keane M and Lyons S (2011) Drugs 
policy in the new programme for government. Drugnet 
Ireland, (37): 1–2.
2. Fine Gael and the Labour Party (2011) Government for 
national recovery 2011–2016. www.taoiseach.gov.ie
Programme for government  (continued)
What’s Working for Children conference
A recent conference focusing on intervention and prevention 
for children, youth and their families, highlighted current 
research and evaluation of evidence-based programmes 
conducted over the last 10 years. What’s Working for 
Children, organised by Archways in conjunction with 
the Offi ce of the Minister for Children and Youth Affairs 
and Atlantic Philanthropies, took place in Dublin in May. 
Barnardos and other organisations working directly and 
indirectly with disadvantaged children also supported the 
conference. Experts in evidence-based practice from the 
US, the UK and Ireland presented the positive outcomes for 
children and families from well-implemented programmes 
and demonstrated the cost effectiveness of these 
programmes to government. 
Over 300 delegates from the community, voluntary and 
statutory sectors, including representatives of drugs task 
forces and other agencies working with children, youth and 
families, attended the conference.
Minister for Children and Youth Affairs Frances Fitzgerald 
delivered the opening address. She spoke about the 
government’s commitment to children and youth in Ireland, 
illustrated by the decision to appoint a full cabinet minister 
and to amalgamate functions relating to children into a 
single department. She also endorsed the value of evidence-
based programmes which she said was a priority 
of government.
Dr Steve Aos, Director of the Washington State Institute for 
Public Policy, spoke about the economic value to be gained 
from implementing evidence-based early intervention 
programmes. The benefi ts include reductions in child 
welfare interventions and in crime levels. Cheryl Hopkins of 
Birmingham City Council outlined the portfolio of evidence-
based programmes that form part of their ‘Brighter Futures’ 
strategy to improve the lives of children and young people 
in Birmingham. The council has allocated an investment of 
£41.7m over 15 years to evidence-based programmes and 
she anticipates a considerable return from this investment 
in terms of better outcomes for children and youth, and 
reduced costs in other areas such as child welfare and 
drugnet 
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Every four years some 40 countries survey their school-aged 
children in order to fi nd out about their health and well-
being, health behaviours and their social context and to 
inform future health promotion policies. Known as the Health 
Behaviour in School-aged Children (HBSC) study, this survey 
uses a methodology and protocol chosen in collaboration 
with the WHO Regional Offi ce for Europe. Ireland has 
participated in this project since the 1990s and the results 
of the fourth iteration of the study in Ireland, undertaken in 
2010, are due to be published in the near future.1 
In undertaking this research and disseminating the fi ndings 
over the years, HBSC Ireland has liaised with various 
stakeholder groups, with one exception – school children 
themselves. Following the completion of the third iteration 
of the survey in 2006, it was decided to rectify this omission. 
The Health Promotion Research Centre at National University 
of Ireland Galway undertook an exploratory study of Irish 
school students’ views on the questions contained in the 
HBSC survey.2
Students aged 10–18 years in mixed gender primary and 
post-primary schools, both advantaged and disadvantaged, 
in urban and rural areas, took part in participatory 
workshops with HBSC researchers. They were invited to 
identify which of the 51 HBSC topics they found most 
interesting and to document what they would like to know 
about the top 12 topics that they had selected. 
The top fi ve ‘most interesting’ topics included, in 
descending order of priority as determined by the school 
students, use of alcohol, puberty, drugs, getting drunk and 
smoking,. The broad types of questions that the workshop 
participants identifi ed in relation to each of these fi ve topics 
are as follows.
1. Alcohol – types and makes, why drink and the cost, age 
and how many, effects, drinking amounts?
2. Puberty – what is it, what happens and why, body 
changes and effects, age and gender, does it hurt, 
pregnancy and sex?
3. Drugs – what are they and types, how are drugs made, 
sources, cost, effects, why use them, addiction and 
quitting?
4. Being really drunk – how it works, how many, how 
much, effects, age and source, why get drunk?
5. Smoking – types and makes, cost and how many, age 
and gender, effects, addiction, quitting?
The authors concluded, ‘Within this study, children have 
clearly articulated the HBSC topics that were of most 
interest to them and what they would like to know about 
these topics, resulting in a reference document for those 
working in health practice and policy. ... The questions that 
the students have about health and well-being need to be 
answered, through both school and out of school settings’ 
(p. 23). 
(Brigid Pike)
1. Reports on the results of the 2002 and 2006 HBSC 
surveys in Ireland may be found in Drugnet Ireland, Issues 
8 and 24. 
2. Doyle P, Kelly C, Cummins G, Sixsmith J, O’Higgins S, 
Molcho M and Nic Gabhainn S (2010) Health behaviour 
in school-aged children: what do children want to know? 
Dublin: Offi ce of the Minister for Children and Youth 
Affairs and the Department of Health and Children.
Drug prevention in the family 
Family policy development, including supports for family-
based drug prevention, could benefi t from a child-centred 
ethos that takes account of the developmental needs 
and rights of individual children. Children’s views on 
what constitutes safe and effective discipline could be 
incorporated into existing parenting programmes that seek 
to provide support for parents. These are just some of the 
conclusions of a recently published study of Irish children’s 
perspectives on parenting styles and discipline.1
The overall aim of this study was to explore the views of 
children and young people, including their perceptions 
of the effects of different parenting styles and disciplinary 
strategies on their lives. A qualitative approach was used, 
involving focus group interviews with children and young 
people aged between 6 and 17 years. The study was carried 
out jointly by the School of Psychology and the Children’s 
Research Centre, Trinity College, Dublin, and the Centre 
for Social and Educational Research in the Dublin Institute 
criminal justice. Dr Karen Blase of the University of North 
Carolina shared her expertise in relation to fi delity in 
implementing evidence-based programmes – ensuring that 
programmes are implemented as they are intended so that 
they achieve the expected results. 
In addition to informative keynote presentations and 
engaging panel question and answer sessions, there were 
12 practice-based seminars which showcased evidence-
based programmes throughout Ireland, including the Triple 
P programme in Longford/Westmeath, Start Strong in 
Ballymun and Incredible Years in Limerick. Several drugs task 
forces support projects based on the Strengthening Families 
Programme. There was a presentation on one of these 
projects, the Mate-Tricks Programme, in the Tallaght West 
Childhood Initiative seminar. 
Further information, including video recordings, speaker’s 
presentations and a summary conference report, is available 
from www.whatsworkingforchildren.org
We would like to thank Eamonn Gillen and Aoife Stack of Dún 
Laoghaire Rathdown Local Drugs Task Force, with input from 
Helen Cahill, for preparing this report of the conference.
What's working for children  (continued)
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Minister for Children and Youth Affairs.
Parenting styles
Children’s descriptions of what parents do in a family 
revealed a variety of parental roles, from providing 
sustenance, protection and support, to monitoring and 
regulating, guiding and teaching, to facilitating children’s 
independence and autonomy. The authors reported that 
parental control was seen as necessary and good, and 
particularly important to prevent children from engaging in 
risk behaviour and to keep them safe, for example to ensure 
they were not ‘going out drinking or doing drugs’, as one 
boy in 1st year said. 
Parent and child roles were perceived to change over 
time, with dependence on parents decreasing as children 
grew older. Given adolescents’ need for autonomy and 
independence, the authors observed that parenting at this 
stage brought novel challenges for regulation and control 
of behaviour at a time when the likelihood of risk-taking 
behaviour may be heightened.
Parental control
The research revealed that Irish parents are important 
fi gures of authority and control for their children. Key 
aspects of this role were perceived to be monitoring and 
checking children’s activities and whereabouts, enforcing 
limits and boundaries, and disciplining children. Parental 
monitoring was reportedly facilitated largely through talking, 
asking questions and via mobile phones. Parents were also 
perceived as ‘all-knowing’ and attentive to familiar and 
unfamiliar patterns of behaviour. 
Older children emphasised the need for parents to negotiate 
rules and regulations with their adolescents, rather than 
imposing restrictions upon them as might be done with 
younger children, and the need to establish trust, which was 
seen as a prerequisite to effective monitoring and developing 
children’s sense of responsibility. A boy in Transition Year 
expressed it thus: ‘Kids have to be trusted, you know. You 
read sometimes about home drug-testing and things like 
that and you think, well it’s obviously going to be something 
wrong with the family dynamic here if the parents are going 
behind their kid’s back to do something like that. Trust your 
kids … you know, give them responsibility.’ (p. 44)
Discipline
Discipline strategies identifi ed by the children were classifi ed 
by the researchers into three categories:
• power-assertive responses, including the removal of 
privileges, time-out, grounding, being allocated extra 
chores or physical punishment;
• inductive responses, involving communication about 
behaviour and its consequences, and reinforcement 
of positive behaviour; and
• love withdrawal, where parents express their 
disappointment in their children with the intention 
of inducing feelings of guilt and regret for 
misbehaviour.
Children’s perspectives on the rationale for physical 
punishment were context-dependent, considering in 
particular the age of the child, frequency and intensity of the 
administration of the physical punishment and the severity 
of the misdeed that elicited such a response. Physical 
punishment was deemed both more effective and more 
acceptable when used with younger children, and then 
should involve only a light slap or tap; the children were 
unanimous in their opposition to frequent or severe physical 
punishment. 
The researchers noted that a key argument in favour of 
physical punishment centred on its effectiveness in curbing 
or preventing health-risk behaviours. Some children in 
the older age groups endorsed parental use of physical 
punishment in contexts where children’s safety and health 
was at risk, such as smoking and drug-related activities. 
(Brigid Pike)
1. Nixon E and Halpenny A M (2010) Children’s perspectives 
on parenting styles and discipline: a developmental 
approach. Dublin: Stationery Offi ce. 
Drug prevention in the family  (continued)
Drugnet digest 
This section contains short summaries of recent reports and 
other developments of interest.
State of the nation's children report: Ireland 2010
On 21 December 2010 the Minister for Children and 
Youth Affairs, Barry Andrews TD, launched the State of the 
nation's children report: Ireland 2010. The third in a biennial 
series, which draws on recent administrative, survey and 
census data on children's lives, the report contains a series 
of indicators highlighting children’s health, educational 
and social, emotional and behavioural outcomes; their 
relationships with family and friends; and services and 
supports for children. 
With regard to the use of psychoactive substances by 
children and young people, the report shows that lifetime 
use of cannabis by 9–17-year-olds increased between 2002 
and 2006 by 3.6%, while the prevalence of daily smoking 
among young people declined by 1.5% over the same 
period. With regard to alcohol, in 2006, 20.4% of children 
aged 10–17 reported that they had been drunk at least once 
in the last 30 days. 
Two indicators illustrate the nature and extent of problems 
associated with the use of psychoactive substances.
 ■ Referrals to the Garda Juvenile Diversion Programme: 
Between 2008 and 2009 the number of children referred 
to the Garda Juvenile Diversion Programme decreased 
substantially, from 21,412 to 18,519. In 2009 alcohol-
related offences were the single highest cause of referrals 
to the programme, representing 17.8% of all referrals; 
possession of drugs accounted for 4.3% of referrals. 
 ■ Admissions to psychiatric hospitals: While the total 
number of children admitted to psychiatric hospitals 
increased from 352 in 2004 to 406 in 2008, the number 
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dependence fell from 32 in 2004 to 17 in 2008 (4.2 % 
of total admitted in 2008 and a rate of 1.6 per 100,000), 
and those diagnosed with an alcohol disorder dropped 
from 17 to 8 (2% of those admitted in 2008 and a rate 
of 0.7 per 100,000).
You can download the report from www.dcya.gov.ie
Offi cial launch of Polish Centre for Addiction Counselling
In June 2011 the Polish Centre for Addiction Counselling 
(CKU) was offi cially launched. To mark the occasion CKU held 
a seminar, Inclusive and Innovative Approach to Addiction 
Counselling in Multicultural Ireland, in conjunction with the 
South Inner City Drugs Task Force (SICDTF) and Coolmine 
Therapeutic Community. The aim of the seminar was to 
address the issue of accessibility of addiction services to ethnic 
minorities in Ireland. Mr Dermot Lacey, chairperson of the 
task force opened the seminar at Dublin’s Mansion House.
CKU was founded in May 2009 in response to demand from 
Polish nationals who could not access mainstream addiction 
services because they did not speak English. CKU provides 
free help and support, through the Polish language, to 
addicts and their families and is supported by the SICDTF. 
The CKU.therapeutic programme is based on the Minnesota 
model. Since its foundation CKU has provided support to 
approximately 300 clients. The service operates on voluntary 
basis and is located in Coolmine House, 19 Lord Edward 
Street, Dublin 2. 
Further information is available at http://ckudublin.org/
Alcohol Action Ireland online guide to services
Alcohol Action Ireland, the national charity for alcohol-
related issues, has launched an online guide to alcohol 
services around the country.The service is called the 
‘Alcohol Service Finder’. Visitors to the AAI website can 
search for services by location or by the age profi le of 
the person for whom help is being sought, using Google 
mapping technology. 
There are six categories in the guide: adults with alcohol 
problems; under-18s with alcohol problems; children 
affected by parental alcohol problems; parents of children 
under 18 with alcohol problems; families of adults with 
alcohol problems; and teens/young adults with alcohol 
problems.
AAI Director Fiona Ryan said: ‘We considered how we could 
best support people in this situation, we consulted and 
found what people wanted was access to targeted, relevant 
information as quickly as possible. So we contacted alcohol 
services across the country and asked if they would be 
included in the guide and then designed it to give people 
what they told us they wanted.’
You can search the Alcohol Service Finder at: www.
alcoholireland.ie/get-help, at www.drinkhelp.ie and at www.
alcoholhelp.ie or by searching for ‘Alcohol Service Finder’ on 
Facebook.
For further information, or comment, contact: 
AAI Communications Offi cer Cathy Gray at 
(01) 878 0610 or (087) 995 0186
(Contributors Brigid Pike, Anne Marie Carew and 
Brian Galvin)
Drugnet digest  (continued)
Inequality and illicit drug use 
The more unequal a society, the higher the level of drug 
use. This fi nding is just one in a study by UK epidemiologists 
Richard Wilkinson and Kate Pickett into the social 
determinants of health, into ‘why health gets worse at every 
step down the social ladder’.1 Ireland was one of 22 ‘rich’ 
countries included in the study. The authors concluded 
that where there is inequality in a country, there is a 
corresponding loss of general health and well-being, as 
indicated by measures of community life and social relations, 
mental health, illicit drug use, physical health and life 
expectancy, obesity, educational performance, teenage births, 
violence, imprisonment and punishment, and social mobility. 
The nub of Wilkinson and Pickett’s argument is that the 
prevalence of poor health and social problems is related 
not to the average standard of living in a country but to the 
degree of inequality (as measured by the disparity between 
the incomes of the richest and the poorest inhabitants). The 
problem is not associated with the overall level of wealth 
in a country but with the size of the difference between 
those with the highest incomes and those with the lowest. 
With regard to illicit drug use, the authors found ‘a strong 
tendency for drug use to be more common in more unequal 
countries’, with Ireland lying just above the midpoint in 
terms of the relationship between drug use prevalence and 
income inequality.2
Widely read and debated, Wilkinson and Pickett’s work has 
been challenged on many grounds – the choice of countries 
studied, the selection of problems to be assessed, and 
failure to control for intervening variables such as national 
culture or welfare system. It has also been asserted that their 
fi ndings were the result of ‘statistical fl ukes’, in other words, 
dependent on the presence of outliers.3 While it is not 
within the remit of Drugnet Ireland to assess the merits or 
otherwise of their approach and their arguments, Wilkinson 
and Pickett’s work provides a framework within which to 
interrogate the new government’s programme Government 
for national recovery 2011–2016 (PGNR),4 and in particular 
to explore whether and how they have made the link 
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policy makers have never made the link explicitly, they have 
made indirect links by associating illicit drug use with socio-
economic disadvantage, marginalisation and exclusion.5
As long ago as 1996, the Ministerial Task Force on Measures 
to Reduce the Demand for Drugs, chaired by Pat Rabbitte 
TD, then Minister of State, recognised the link between 
drug misuse and socio-economic disadvantage. The task 
force recommended the establishment of drugs task forces 
in areas experiencing high levels of drug misuse, which 
also coincided with areas experiencing social and economic 
deprivation. Since 2001 Ireland’s national drugs strategies 
have set the drugs issue within the wider policy context 
of social inclusion, to which a number of other national 
strategies in Ireland, such as health, anti-poverty and 
education, are also linked.6 
In the PGNR, the government brings two new terms to 
the fore in relation to social policy – fairness and equality. 
In their introductory Statement of Common Purpose, 
the coalition partners state: ‘We are both committed to 
forging a new Ireland that is built on fairness and equal 
Citizenship. ... By the end of our term in Government Ireland 
will be recognised as a modern, fair, socially inclusive and 
equal society supported by a productive and prosperous 
economy.’ Along with chapters on the Economy, Reform and 
Progress, the PGNR contains a chapter on Fairness. 
Although the authors of the PGNR do not defi ne fairness, 
the measures in the chapter on Fairness are placed within 
the context of principles which, it may be assumed, the 
government believes will lead to a fair society – social 
solidarity, social inclusion, and reduction of stigma. With 
regard to equality, the chapter on Fairness does provide 
some explanation: under the heading Equality and Social 
Protection, the authors describe equality as being at the 
heart of what it means to be a citizen in Ireland’s democracy: 
‘The government believes that everyone has the right to be 
free from discrimination and that we all benefi t from living in 
a more equal society.’ The government commits to ensuring 
equal access to health and to education, and lists measures 
to ensure equality and social inclusion for women and 
men, Travellers, members of the lesbian, gay bisexual and 
transgendered community, workers, members of minority 
ethnic groups and immigrants, and people with disabilities. 
Although the drugs issue is addressed in the chapter on 
Fairness, at no point is policy to tackle the illicit drugs 
problem mentioned in conjunction with either equality or 
the concepts and principles understood to underpin fairness. 
The drugs issue is included the section entitled Justice and 
Law Reform, and four broad objectives are listed:
• to introduce a combined drugs and alcohol strategy 
(a ‘national addiction strategy’),
• to provide ‘renewed impetus to the fi ght against 
drugs’,
• to ensure that the drugs strategy ‘once again 
becomes relevant and effective’, and
• to enhance, where possible, ‘the demand reduction 
strategies’. 
Although not as clear or unambiguous as recent statements 
on drug policy by the governments in Britain and Denmark,7 
the new Irish government’s stated objectives suggest, as 
much by omission as inclusion, that a shift in emphasis may 
be occurring. This is borne out by the 12 ‘key priorities 
for short-term implementation’ listed alongside the four 
objectives, which focus on supply reduction, prevention 
and rehabilitation; just one action refers to harm reduction, 
increasing the number of needle exchange programmes 
as well as the number of rehabilitation places throughout 
the country. 
The new government’s reallocation of responsibilities for 
Ireland’s drugs policy, detailed elsewhere in this issue of 
Drugnet Ireland, does not help to clarify its thinking on 
the nature of the links between the drugs problem and 
other social policy issues. Prior to the February election, 
responsibility for drugs policy had come to be located in 
the same government department as community and local 
development, equality and social inclusion policy, suggesting 
a common goal or shared aspiration among all these policy 
domains. The new government’s transfer of functions sees 
these four policy areas separated once again and assigned to 
four different government departments. 
How the Department of Health will approach its new 
function of co-ordinating the national drugs strategy remains 
to be seen. In their study of the links between health, social 
problems and inequality, Wilkinson and Pickett argued that 
policy makers should integrate health and social problems 
as elements of a single policy problem – inequality – rather 
than approach them as separate issues: 
Attempts to deal with health and social problems through 
the provision of specialized services have proved expensive 
and, at best, only partially effective. ... Rather than reducing 
inequality itself, the initiatives aimed at tackling health and 
social problems are nearly always attempts to break the links 
between socio-economic disadvantage and the problems 
it creates. The unstated hope is that people – particularly 
the poor – can carry on in the same circumstances, but will 
somehow no longer succumb to mental illness, teenage 
pregnancy, educational failure, obesity or drugs. (pp. 238–9)
(Brigid Pike)
1. Wilkinson R and Pickett K (2010) The spirit level: why 
equality is better for everyone. Published with revisions 
and a new postscript. London: Penguin Books. 
2. The authors obtained data on drug use in the 22 
countries, as reported in the World drug report compiled 
annually by the United Nations Offi ce on Drugs and 
Crime, and plotted this against the level of income 
inequality in the countries, as reported in the Human 
development report compiled annually by the United 
Nations Development Programme.
3. A full account of the criticisms and the authors’ 
responses may be found at www.equalitytrust.org.uk/
resources/other/response-to-questions
4. Fine Gael and the Labour Party (2011) Government for 
national recovery 2011–2016. www.taoiseach.gov.ie 
5. An exception is the strategic plans of the newly-
established regional drugs task force, completed in 
2005, some of which explicitly discussed the relationship 
between illicit drug use and social exclusion and 
inequality. See Pike B (2006) RDTF strategies push out 
the boundaries. Drugnet Ireland, (20): 11–12.
6. See, for example, the National Drugs Strategy 2001–2008 
(Department of Tourism, Sport and Recreation, 2011) 
para. 6.1.9, and the National Drugs Strategy 2009–2016 
(Department of Community, Rural and Gaeltacht Affairs 
2009) para. 6.21.
Inequality and illicit drug use  (continued)
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Human rights and extreme 
poverty in Ireland
Between 10 and 15 January 2011, at the 
invitation of the then Irish government, the 
UN’s independent expert on human rights and 
extreme poverty, Magdalena Sepúlveda Carmona, 
undertook a mission to Ireland. She focused on 
the impact of the economic and fi nancial crises in 
Ireland and the effects of recovery measures on the 
level of enjoyment of human rights, in particular 
economic, social and cultural rights, by the most 
vulnerable individuals and groups in Ireland, 
including problem drug users. On 17 May 2011 
Ms Sepúlveda submitted her report to the UN. In 
it, she makes concrete recommendations on how 
to implement a human rights-based recovery in 
Ireland.1
While acknowledging that the government’s anti-
poverty and social inclusion strategies may need 
to be adapted in light of the worsening economic 
situation, she encourages the government to 
ensure as a minimum that the 23 high-level goals 
in Towards 2016 continue to be the primary targets 
for Ireland’s social policies. She also endorses the 
target set by the National Action Plan for Social 
Inclusion 2007–2016 to reduce the number of 
those experiencing consistent poverty to between 
2% and 4% by 2012, with the aim of eliminating 
consistent poverty by 2016. 
Ireland’s human rights obligations apply even 
during times of economic hardship, and recovery 
measures must not disproportionately impact 
the poorest segments of society, according Ms 
Sepúlveda. She calls on the government to 
undertake a human rights review of all budgetary 
and recovery policies to ensure they comply with 
fundamental human rights principles.
According to the independent expert, having 
signed and ratifi ed the International Covenant on 
Economic, Social and Cultural Rights, Ireland must 
devote the maximum available resources to ensure 
progressive realisation of all economic, social and 
cultural rights by its population. Given that Ireland 
remains an affl uent country with a relatively high 
GNP per person, Ms Sepúlveda expresses concern 
about the level of taxation in Ireland, which 
she notes is lower than in most other European 
countries: ‘... seeking to achieve adjustments 
primarily through expenditure cuts rather than tax 
increases might have a major impact on the most 
vulnerable segments of society. Reductions in public 
expenditure affect the poorest and most vulnerable 
with the most severity, whereas some increase in 
taxation rates could place the burden on those who 
are better equipped to cope. ’
Ensuring non-discrimination and equality are 
regarded as fundamental pillars of the human rights 
framework. Despite the existence of a strong body 
of equality legislation in Ireland, Ms Sepúlveda 
urges the government to be particularly mindful 
that policies do not exacerbate the challenges 
faced by groups vulnerable to discrimination, such 
as single mothers, children, Travellers, people 
with disabilities, migrants, asylum-seekers and the 
homeless. She also encourages the government 
to take positive measures to help these vulnerable 
segments to ‘regain their equal footing with the 
rest of Irish society’. She goes on to observe:
A number of recent measures are 
concerning in this respect, especially 
reductions in child benefi ts and benefi ts for 
job seekers, carers, single parent families, 
persons with disabilities and blind persons. 
The impact of these measures will be 
exacerbated by funding reductions for a 
number of social services which are essential 
for the same vulnerable people, including 
disability, community and voluntary 
services, Travellers supports, drug outreach 
initiatives, rural development schemes, the 
Revitalising Areas by Planning, Investment 
and Development (RAPID) programme and 
Youthreach. (para. 34)
(Brigid Pike)
1. Report of the independent expert on the question 
of human rights and extreme poverty, Magdalena 
Sepúlveda Carmona. Addendum: Mission to 
Ireland. United Nations General Assembly, 
Human Rights Council, Seventeenth Session, 
17 May 2011. A/HRC/17/34/Add.2
7. McKeganey N (2011) From harm reduction 
to drug user abstinence: a journey in drug 
treatment policy, Journal of Substance Use, 16(3): 
179–194, traces a recent policy shift in Britain 
from the goal of harm reduction to one of drug 
user abstinence, while Houborg E and Bjerge B 
(2011) Drug policy, control and welfare, Drugs: 
education, prevention and policy 18 (1): 16–23, 
describe how the welfarist political rationality that 
underpinned Denmark’s drug ‘policy space’ in 
the 1970s and 1980s has been superseded over 
the last two decades by a ‘New Right’ political 
rationality combining a tough-on-crime policy 
with the marketisation of drug service provision.
Inequality and illicit drug use  (continued)
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TILDA reports alcohol use 
and dependence 
The Irish Longitudinal Study on Ageing (TILDA) is a detailed 
study of the health, lifestyles and fi nancial situation of 
8,000 to 10,000 people as they grow older and as their 
circumstances change over a 10-year period. The study is 
being carried out by Trinity College Dublin in collaboration 
with an inter-disciplinary panel of scientifi c researchers 
who have expertise in various fi elds of ageing. TILDA is 
funded by the Department of Health, Irish Life and Atlantic 
Philantropies. The information gathered in TILDA will 
improve our understanding of the factors that aid successful 
ageing in Ireland. 
The fi rst results from this study have now been published.1 
The section on alcohol in chapter 5 of the report includes 
the following (cross-references removed):
TILDA respondents were asked about the frequency of their 
alcohol consumption as well as the quantity of alcohol 
consumed within the preceding six months. Respondents 
were also asked if [at any stage in their life] a doctor had 
told them that they suffered from alcohol or substance 
abuse. In addition, respondents completed the CAGE (cut-
annoyed-guilty-eye) questionnaire, which consists of four 
questions evaluating alcohol patterns and behaviour and is a 
valid screening assessment for is a valid screening assessment 
for alcoholism. 
Overall 1.8% of older Irish adults report a diagnosed history 
of alcohol or substance abuse. The rate is highest in men 
aged 65-74 years (3.9%). No association with education is 
observed. Individuals in the lowest wealth quartile are more 
likely to report a diagnosis of alcohol and substance abuse 
compared to those in the highest wealth quartile. When 
alcohol problems are assessed using the CAGE questionnaire, 
a different pattern emerges. The overall prevalence of 
’problem drinking‘ (defi ned as a CAGE score of 3 or more) is 
higher at 4.8% and no association with wealth or education 
is observed. 
Table 1 Problematic alcohol use and diagnosed 
substance abuse, by age and sex
Alcohol problem 
using CAGE
Diagnosed alcohol 
or other drug misuse
% (95% CI)  % (95% CI)
Male
50–64 8.6 (7.3–10.2) 3.2 (2.4–4.2)
65–74 6.0 (4.5–8.0) 3.9 (2.9–5.4)
>=75 2.4 (1.2–4.5) 0.7 (0.3–1.8)
Total 7.0 (6.1–8.2) 3.0 (2.4–3.7)
Female
50–64 4.0 (3.2–5.1) 1.0 (0.7–1.6)
65–74 1.5 (0.8–2.8) 0.5 (0.2–1.3)
>=75 0.6 (0.2–2.1) 0.1 (0.0–0.6)
Total 2.7 (2.2–3.4) 0.7 (0.5–1.0)
All
50–64 6.3 (5.5–7.2) 2.1 (1.6–2.7)
65–74 3.7 (2.8–4.8) 2.2 (1.6–3.0)
>=75 1.3 (0.7–2.3) 0.3 (0.1–0.8)
Total 4.8 (4.2–5.4) 1.8 (1.5–2.2)
Source: After Barret et al. (2011), Table 5.A23, p. 120.
(Abstracted by Jean Long)
1. Barrett A, Savva G, Timonen V and Kenny RA (eds) 
(2011) Fifty plus in Ireland 2011: fi rst results from the 
Irish longitudinal study on ageing (TILDA). Dublin: Trinity 
College Dublin. www.drugsandalcohol.ie/15040
UN reviews responses to world drugs 
problem
2011 marks the 50th anniversary of the 1961 Single 
Convention on Narcotic Drugs. An important a milestone 
in international drug control, this convention codifi ed all 
existing multilateral treaties on drug control and extended 
the existing control systems to include the cultivation of 
plants grown as the raw material of narcotic drugs. 
While the UN’s Commission on Narcotic Drugs (CND), 
the central policy-making body of the United Nations in 
drug-related matters, acknowledged this anniversary, it 
was business as usual at the CND’s 54th annual meeting in 
Vienna. Four resolutions passed at the meeting relevant to 
drug policy issues currently being addressed in Ireland are 
noted here.1
54/2: Promoting international co-operation to prevent 
drug-affected driving
Member states are urged to develop national responses to 
address the issue of drug-affected driving by assessing and 
monitoring the magnitude of the phenomenon at national 
level and by exchanging information and best practices on 
effective responses. They are also encouraged to develop 
effective roadside testing options to assess drug-affected 
driving and to raise public awareness. With regard to this 
last issue, member states are invited to ensure measures are 
consistent with measures tackling other road safety risks, 
such as driving under the infl uence of alcohol.
drugnet 
IRELAND
12
54/5: Promoting rehabilitation- and reintegration-
oriented strategies in response to drug use disorders 
and their consequences that are directed at promoting 
health and social well-being among individuals, families 
and communities
Member states are encouraged to ensure that drug demand 
reduction policies and practices include access to evidence-
based and humane treatment, care and related support 
services aimed at rehabilitating and reintegrating people 
suffering from drug dependence and drug-related diseases, 
and that these services focus on health and social well-being 
among individuals, families and communities. They are also 
encouraged to provide a diverse range of treatment facilities, 
including medically assisted and psychosocial treatment and 
rehabilitation, that match the needs of dependent drug users 
in all relevant social and clinical conditions, and exhorted 
to improve the availability and coverage of these services 
as part of their country’s overall health-care system. Finally, 
they are urged to identify and fi rmly counter discrimination 
against drug users, and to develop effective interventions 
that lead to social reintegration, including programmes 
that facilitate the employment of people in treatment and 
recovery that are tailored to their specifi c needs in the 
rehabilitation process. 
54/8: Strengthening international co-operation and 
regulatory and institutional frameworks for the control 
of precursor chemicals used in the illicit manufacture of 
synthetic drugs
Acknowledging that the diversion of pharmaceutical 
preparations containing ephedrine and pseudoephedrine is 
a concern because these may not be subject to similar levels 
of control as bulk (raw) ephedrine and pseudoephedrine, 
the meeting identifi ed a wide range of actions to address the 
issue. These included strengthening legislative and regulatory 
frameworks, monitoring and controlling all points of entry 
to and exit from countries, including communications 
via the Internet, improving information-sharing with 
the International Narcotics Control Board (INCB) and 
collaborating with the national chemical industry. 
54/11: Improving the participatory role of civil society in 
addressing the world drug problem
Member states are encouraged to ensure that civil society 
plays a participatory role, where appropriate, through 
consultation, in the development and implementation of 
drug control programmes and policies, in particular with 
regard to aspects of demand reduction. Member states are 
also encouraged to cultivate an environment that promotes 
innovation and to take into account promising approaches 
taken by civil society to assist governments in their efforts 
to address the world drug problem, provided that such 
approaches are in conformity with the international drug 
control conventions, are based on scientifi c evidence, and 
are in accordance with relevant human rights obligations.
Other items on the CND meeting agenda included (1) 
round-table discussions on regional and international co-
operation to combat the world drug problem and its links 
with organised crime, revitalising the principle of common 
and shared responsibility for the world drug problem, 
and addressing key public health issues such as addictive 
behaviours by youth and drugged driving; (2) a review 
of the implementation of the international drug-control 
treaties, including consideration of the annual report of the 
INCB; and (3) a review of the implementation of the UN’s 
political declaration and 10-year action plan, agreed in 
2009, to counter the world drug problem.2 
(Brigid Pike)
1. The full text of these resolutions, together with other 
10 resolutions passed at the meeting, are contained 
in the advance unedited offi cial report issued by the 
Commission on Narcotic Drugs, Report on the fi fty-
fourth session (2 December 2010 and 21-25 March 2011) 
Economic and Social Council Offi cial Records, 2011, 
Supplement No. 8 (E/2011/28–E/CN.7/2011/15) http://
www.unodc.org/unodc/al/commissions/CND/session/54.
html As Ireland is not currently a member of the CND, 
the Irish delegation attended with observer status. 
2. Accounts of the CND meeting have been posted on the 
internet by international NGOs, including a summary 
of the main events and analysis of the key discussions 
and debates, compiled by the International Drug Policy 
Consortium http://www.idpc.net/publications/2011-
cnd-proceedings-document , and a detailed account 
accessible on the International Drug Policy Consortium–
International Harm Reduction Association CNDblog at 
http://www.cndblog.org/ For further information on 
Ireland and UN drug policy, see Drugnet Ireland, Issues 8, 
18, 22, 27, 30 and 34.
Responses to world drugs problem  (continued)
Experiences and health effects of head 
shop substances in Ireland
A number of short articles or letters published in journals 
in the past six months have reported adverse health 
events associated with the use of psychoactive substances 
sold in head shops and on line. Summaries of these articles 
are presented below in the form of edited extracts from 
the journals. 
Mephedrone and ‘head/hemp’ shop drugs: a clinical and 
biochemical ‘heads up’
This editorial1 emphasises that it is important that primary 
care physicians, the emergency services and psychiatric 
specialists realise that they need to consider these drugs 
when cases present with drug-induced psychoses and/or 
suicide ideation (thoughts of and plans for suicide). Some 
of these drugs can be detected using laboratory standards, 
the standards and equipment required for identifying these 
drugs are only available in specialist toxicological laboratories 
and the Drug Treatment Centre Board. 
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Users’ experiences of cathinones sold in head shops 
and online
This paper2 describes the use and effects of head shop 
powders among opiate-dependent polydrug users and 
recreational drug users in Dublin. These powders contained 
cathinones and were sold as bath salts or plant food via 
the internet or in head shops. As this is a relatively new 
phenomenon, a qualitative approach using three data 
sources, in-depth interviews, a focus group (of 10 opiate 
users) and a head shop website containing 49 product 
reviews, was employed. A thematic approach was used to 
analyse the data. 
According to the study population, these powders mimic 
the effects of cocaine, ecstasy and amphetamines. These 
substances were snorted, ingested or injected by people 
and were not used as bath salts or plant food. The users’ 
experience indicates that these powders have the potential 
for dependence, and exhibit side effects such as insomnia, 
anxiety and other more serious mental health effects. The 
users report that the effects of the substances vary over 
time, indicating that the chemical contents of the powders 
may change.
Though users’ descriptions of effects varied, there were 
indications of health and dependency effects which were 
more severe and more common among problematic opiate 
users when compared to the recreational drug users, who 
also experienced increased social vulnerability. In general, 
the recreational drug users considered their side effects to be 
mild and worth the drug-induced experience.
Two psychiatric presentations linked with ‘head shop’ 
products
This paper3 reports two cases of acute onset of and 
rapid recovery from psychotic symptoms, the fi rst after 
eating a head shop product and the second after injecting 
it; the product probably contained methylone. Common 
psychotic symptoms include hallucinations, delusions, and 
disturbed thoughts.
A 30-year-old woman with no past psychiatric history 
attended a Dublin emergency department with a 24-hour 
history of restlessness, irritability, paranoid delusions and 
maculo-papular rash on the lower third of her right thigh 
and on upper third of both thighs. Physical examination 
revealed raised and fl uctuating blood pressure and 
pulse rates with peaks of 160/100mmHg and 120bpm 
respectively. Her brain scan and lumbar puncture (spinal 
fl uid) were normal. Her urine test was negative for ‘common’ 
illicit substances.
A 29-year-old man with no fi xed abode and a long history 
of injecting drug use attended the same emergency 
department with signs of a recent onset and fl orid psychotic 
episode (evidenced by hallucinations and delusions). On 
examination, he was quite agitated and described hearing 
voices and seeing visual hallucinations. He had delusions 
(beliefs not backed by reality)and also reported passing 
thoughts about suicide. He also described some sub-clinical 
symptoms of depression. There were no abnormalities 
identifi ed during the physical examination, and the only 
abnormal laboratory fi ndings were his urine tested positive 
for opiates and benzodiazepines. He was already attending 
the addiction services for methadone maintenance therapy. 
He had no past history of psychotic or mood disorder. 
Both cases were admitted to hospital for fi ve days and were 
treated with an atypical antipsychotic and a benzodiazepine. 
Their symptoms settled within 48 hours of admission. 
Whack induced psychosis: a case series
‘Whack’ is a new psychoactive substance available until 
recently in head shops. It contains two active constituents, 
4-fl uorotropacocaine and desoxypipradrol. 
On 9 May 2010, the Health Service Executive (HSE) issued 
an emergency warning about Whack, as in the preceding 
10 days, 40 people attended emergency departments or 
general practitioners suffering side-effects from the drug. 
The majority of these cases were young males in their 
twenties from different regions in Ireland. A range of physical 
symptoms were reported, including fast pulse, high blood 
pressure and diffi culty in breathing. The majority of cases 
also experienced anxiety and at least seven were reported to 
have experienced psychotic symptoms. None of these cases 
have been reported in the medical literature to date.
This paper4 presents two case studies of men who developed 
acute psychotic states after using Whack. There was a 
striking similarity between the two cases symptoms, with 
initial euphoria and disinhibition followed by severe anxiety, 
insomnia, depressed mood, restlessness, agitation, pacing 
and psychosis. These symptoms persisted for 7–10 days 
after using Whack. Both men required inpatient treatment 
but displayed a good treatment response to atypical 
antipsychotic agents. This is the fi rst published case series 
relating to this psychoactive substance in Ireland.
Benzylpiperazine-induced acute delirium in a patient 
with schizophrenia 
Benzylpiperazine is a psychotropic compound that has been 
widely available until recently from ‘head shops’. This report5 
describes the case of a 48-year-old man with schizophrenia 
who developed an acute delirium or confusion secondary 
to benzylpiperazine use. This is the fi rst documented case of 
delirium due to benzylpiperazine use in Ireland. Investigation 
of his delirium unearthed a temporal meningioma, which 
appears to be an unrelated or supplementary fi nding. 
New Doves: a new legal high? 
This letter to the editor6 reports two cases of people who 
sought medical assistance after taking butylone (sold as 
London Underground Doves). The fi rst case was that of a 
25-year-old woman who experienced dilated pupils, facial 
fl ushing and tachycardia (fast pulse). The second was that 
of a 37-year-old man who experienced vomiting, abdominal 
pain, palpitations and chest pain. Both cases recovered 
following symptomatic treatment. 
Headshop heartache: acute mephedrone 'meow' 
myocarditis 
This paper7 presents a case study of 19-year-old man who 
came to hospital with crushing chest pain 20 hours after 
eating a gram of plant food containing mephedrone. His 
history and urinalysis indicated that he had not taken other 
drugs. His electrocardiograph (ECG) showed an abnormal 
heart rhythm (ST elevation) and his MRI confi rmed the 
abnormal heart rhythm and showed swelling of the heart 
muscle. The patient recovered after fi ve days in hospital. 
The authors report that it is not clear how mephedrone 
induces infl ammation of the heart but it is though that such 
damage to the heart could cause death; it is speculated that 
mephedrone has caused a number of deaths in the UK and 
confi rmed that it has caused one death in Sweden. 
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Drug Treatment Court reports progress
In May 2010, the Minister for Justice and Law Reform, 
Dermot Ahern TD, published a review by his department of 
the Drug Treatment Court (DTC) which has been operating 
in Dublin since 2001.1
Highlighting the low number of participants entering and 
successfully completing the DTC Programme, the review 
made several recommendations designed to improve 
the court’s operational effectiveness and overall success 
rate.2 It was decided that, having implemented the 
recommendations, the DTC should continue its operations 
for a further two years.
Although the review found that only 14% of programme 
participants had graduated from the programme since its 
establishment, participation in the programme was seen 
to have had a positive effect on behaviour. Although many 
participants took several years to progress through the 
initial phases of the programme, the focused attention and 
support they received during this period had ‘a positive 
effect on their offending behaviour, as well as on their health 
and personal relationships’, even if they ultimately failed to 
complete the programme (p. 19). Writing on page 5 of the 
March issue of Courts Service News,3 Tom Ward, chief clerk of 
the Dublin Metropolitan District Court, reports on how the 
programme has been adapted to address this issue: 
The principal achievement over the past year has been 
the agreement of a new strength’s based approach to 
determining the progress of participants… . Under the 
new system, participants continue to be tested as part of 
their treatment with progress measured over the period of 
participation. A greater weighting is ascribed to positive 
behaviours, such as not coming to unfavourable notice of 
the Gardaí. Participants receive credits for attending the 
in-house support group which is based on the ‘12 steps’ 
approach to managing addictions. Interim achievements 
are recognised and those who achieve a silver standard, 
but do not manage to attain gold, may be the subject of 
a report from the Drug Treatment Court Judge to their 
Sentencing Judge, proposing a suspended rather than a 
custodial sentence. 
Attending a recent Drug Treatment Court presentation were (l to r): Hilda McDermott, DTC co-ordinator; Garda Liam 
Reynolds, DTC; Fiona Carolan, DTC education co-ordinator; David Patten, DTC graduate; Linda O'Driscoll, DTC liaison 
nurse; and Declan Donnelly, DTC probation offi cer 
(Compiled by Jean Long)
1. O'Domhnail S and Ni Chleirigh C (2011) Editorial: 
Mephedrone and ‘head/hemp’ shop drugs: a clinical 
and biochemical ‘heads up’. Irish Journal of Psychological 
Medicine, 28(1): S2–S3.
2. O'Reilly F, McAuliffe R and Long J (2011) Users’ 
experiences of cathinones sold in head shops and online. 
Irish Journal of Psychological Medicine, 28(1): S4–S7.
3. Uhoegbu C, Kolshus E, Nwachukwu I, Guerandel A and 
Maher C (2011) Two psychiatric presentations linked 
with ‘head shop’ products. Irish Journal of Psychological 
Medicine, 28(1): S8–S10.
4. El-Higaya E, Ahmed M and Hallahan B (2011) Whack 
induced psychosis: a case series. Irish Journal of 
Psychological Medicine, 28(1): S11–S13.
5. Tully J, Hallahan B and McDonald C (2011) 
Benzylpiperazine-induced acute delirium in a patient 
with schizophrenia and an incidental temporal 
meningioma. Irish Journal of Psychological Medicine, 
28(1): S14–S16.
6. Herbert J and Tracey JA (2010) New Doves: a new legal 
high? Irish Medical Journal, 103(3): 92–93.
7. Nicholson PJ, Quinn MJ and Dodd JD (2010) Headshop 
heartache: acute mephedrone 'meow' myocarditis. Heart, 
96(24): 2051–2052.
Head shop substances  (continued)
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Supreme Court overturns mandatory 
drug sentence
A recent decision by the Supreme Court to overturn a 10-
year prison sentence for drug possession has raised doubts 
about the operation of legislation under which sentences 
are determined based on the estimated market value of 
seized drugs.1 
What follows is an abridged extract from the judgement 
setting aside the conviction as delivered by Mr Justice 
Fennelly in the Supreme Court on 15 February 2011.
In the original trial it was alleged that the appellant in this 
case had in his possession for the purpose of sale or supply 
amphetamines with a market value of €13,000 or more 
contrary to section 15A (as inserted by section 4 of the 
Criminal Justice Act, 1999) and section 27 (as amended 
by section 5 of the Criminal Justice Act, 1999) of the 
Misuse of Drugs Act 1977. This offence attracts a minimum 
presumptive sentence of 10 years’ imprisonment. 
Counsel for the appellant submitted at trial that the proof 
of value of the drugs proffered by the prosecution was 
insuffi cient and that he had no case to answer. The trial 
judge refused his application for a direction. The appellant 
appealed against his conviction to the Court of Criminal 
Appeal on the single ground that: 
… there was no evidence on which a properly 
directed jury could come to the conclusion and be 
satisfi ed beyond a reasonable doubt that the market 
value of the drugs concerned was €13,000 or more. 
The Court of Criminal Appeal concluded that there had 
been no error of law in the original trial. However, the CCA 
referred the following matter to the Supreme Court to be 
determined2 as a question of law of exceptional importance:
In a prosecution pursuant to section 15A of the 
Misuse of Drugs Act 1977, for the purpose of 
ascertaining the amount of a controlled substance 
present in a powder in a sealed container or in 
a number of such containers proven by expert 
evidence to contain that particular controlled 
substance, may the amount of that controlled 
substance present in the powder be established 
by the oral evidence of an expert as to the range 
within which amounts of that controlled substance 
in other powders generally fell and, if the answer is 
in the affi rmative, must the prosecution disclose to 
the defence a statement or a report by that expert 
setting out the facts upon which her or his opinion as 
to that range is based?
The primary issue considered by the Supreme Court was 
the suffi ciency of proof required to determine the value of 
drugs. The appellant had been arrested in possession of 
approximately ten kilograms of amphetamines packed in 
10 separate bags. At trial, a member of the Garda 
National Drugs Unit estimated the value of the drugs at 
€145,755, using a price of €15,000 per kilo. The Garda 
assumed that each of the packs of amphetamine contained 
at least 10% of amphetamine. It was accepted that proof of 
the actual contents and percentage of amphetamine present 
was a matter to be determined by the Forensic Science 
Laboratory (FSL).
A scientist of the FSL explained that she had analysed fi ve 
of the packs and could say with 100% certainty that the 
fi ve packs contained amphetamine, but not how much. She 
added that, taking into account the general appearance 
of the packs and the powder her professional opinion was 
that it was highly unlikely that any of the packs would be 
negative. However, she stated further:
I can’t say for defi nite what the purity of the 
samples are but I can give a range in which 
amphetamine purities generally fall between that 
is maybe 10 and 40% but the samples were not 
quantifi ed because quantifi cation is not a routine 
course of qualitative analysis so I cannot put an 
exact fi gure on the purity…
Progress is also reported on the establishment of a new 
Support and Advisory Committee to assist the Court. This 
comprises senior managers from the Health Service Executive, 
An Garda Síochána, the Probation Service, City of Dublin 
VEC, the Health Research Board and the Courts Service.
According to Mr Ward, ‘The Court hopes to be able to 
accept participants with addresses outside the Dublin North 
Inner City in the near future. In the meantime, it continues 
to encourage referrals from those with addresses in Dublin 
1, 3 or 7.’ 
The review of the DTC recommended that the programme 
be extended to offenders aged 16–18 years who are before 
the Children Court. The current programme for government 
is also committed to carrying out ‘a full review of the 
Drug Treatment Court programme to evaluate its success 
and potential in dealing with young offenders identifi ed 
as having serious problems with drugs’.4 An interim 
assessment of the DTC is due to take place in the autumn 
(Tom Ward, personal communication, June 2011). This will 
examine the progress made to date in implementing the 
recommendations of the review.
For more information about the DTC, phone 01-8886294 or 
e-mail drugtreatmentcourt@courts.ie.
(Johnny Connolly)
1. Department of Justice, Equality and Law Reform (2010) 
Review of the Drug Treatment Court. Dublin: Stationery 
Offi ce. Available at www.justice.ie
2. See Connolly J (2010) Drug Treatment Court to continue 
operating. Drugnet Ireland, (35): 23.
3. Ward T (2011) New look Drug Treatment Court offers 
hope for the future. Courts Service News (13): 5. Dublin: 
Courts Service.
4. Fine Gael and the Labour Party (2011) Government for 
national recovery 2011–2016. www.taoiseach.gov.ie 
(p. 20). 
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Supreme Court overturns mandatory drug sentence  (continued)
In further cross-examination, the scientist agreed that the 
presence of as little as 1% would trigger the test she had 
carried out, but repeated that the range is generally between 
10% and 40%. 
[Mr Justice Fennelly then explained the nature of the 
proof required to secure a conviction under the relevant 
legislation.] 
Proof of value is an essential ingredient of the offence 
under section 15A. It is what distinguishes it from 
the offence of possession for sale or supply of an 
unquantifi ed and unvalued amount of drugs. Most 
importantly, it is what has caused the Oireachtas, 
subject to exceptional mitigating circumstances, to 
mark the offence as one of extreme seriousness such 
as to require the court, in sentencing a convicted 
person, to impose a penalty of a minimum of ten 
years’ imprisonment. The ingredient of value must 
be proved to the satisfaction of the jury beyond 
reasonable doubt.
At the original trial, the forensic scientist established the 
presence of amphetamine in each of the fi ve packs she 
had analysed, but had not determined the extent of the 
amphetamine content and was therefore unable to say ‘for 
defi nite’ what the level of presence of amphetamine was. 
She said that the range in which amphetamine purities 
‘generally fall’ was between 10% and 40%. 
Everything turns on the meaning to be attributed to the 
word ‘generally’. It is a word of fl exible use. It may imply, 
perhaps, that a majority of cases fall within that range, but, 
in a weaker sense, may mean no more than ‘commonly’. If 
the facts were that analysis of seized drugs for amphetamine 
always or nearly always falls within the 10/40% range, one 
might have expected the witness to say so. Instead, she 
used the word ‘generally’ three times. In its normal usage 
the word leaves open the very real possibility that there are 
cases outside that range. It cannot be assumed that Dr Casey 
meant any more than that there was probably 10% to 40% 
amphetamine present. Probability is not enough. 
The evidence did not exclude the very real possibility that 
the percentage of amphetamine present could have been 
as low as 1%. Such a percentage was suffi cient to produce 
the result which she obtained from her test. However, if that 
were the case the value of those drugs would be less than 
the amount required to sustain a conviction for the offence 
in issue.
The proof of value is an objective matter. In this case it was 
not suffi cient for the prosecution to prove the mere presence 
of amphetamine and to rely on an unexplained range of 
values which generally applies without evidence which 
addressed the extent to which there are cases outside the 
range. This left a gap in the prosecution evidence. I believe 
that the case should have been withdrawn from the jury. I 
would allow the appeal and set aside the conviction of the 
appellant in respect of count number 1 on the indictment.
I would not direct a retrial. There is no reason to believe 
that Dr Casey would be in a position to give any different 
evidence on another occasion.
(Compiled by Johnny Connolly)
1. Director of Public Prosecutions v Connolly [2011] IESC 6. 
Supreme Court. Judgement by Fennelly J. www.courts.ie/
judgments.nsf
2. As provided for pursuant to section 29 of the Courts 
of Justice Act 1929, as substituted by section 22 of the 
Criminal Justice Act 2006. 
The social norms approach to tackling 
substance use
What are the underlying assumptions of the social 
norms approach? 
Numerous surveys have shown that young people tend to 
overestimate the prevalence (behaviour) and acceptance 
(attitudes) of substance use among their peers. It is assumed 
that young people are strongly infl uenced by what they 
perceive to be the group norms among their peers (norms = 
behaviours and attitudes) hence there is a strong likelihood 
that they will think and behave in similar ways. For example, 
if they perceive that binge-drinking of alcohol is the norm 
among their peers, a) they will form the belief/attitude 
that it is expected of them and b) they will engage in such 
behaviour. In such cases, they may ignore the information 
campaigns that tell them the dangers of consuming large 
amounts of alcohol or the long-term adverse effects of 
smoking tobacco and/or cannabis. 
Why is this approach gaining favour? 
McAlaney and colleagues1 state in a recent paper on the 
international development of the social norms approach to 
drug education and prevention: ‘The growth of the social 
norms approach is perhaps partially explained by growing 
disenchantment with conventional prevention approaches.’
Such approaches include providing information awareness 
(drug education) on the adverse consequences of substance 
use, affective education where interventions seek to improve 
self-esteem and, to some extent, the life-skills approach, 
particularly when targeting ‘at-risk’ youth. All these 
conventional approaches are coming in for criticism and 
are increasingly viewed as being ineffective in preventing, 
delaying or reducing substance use among young people. 
What are the key components of the social norms 
approach and how is it delivered? 
Reliable data are required on what young people perceive to 
be the norm in a) peer attitudes towards substance use, and 
b) peer behaviour in relation to substance use. Reliable data 
are also required on a) actual attitudes towards substance 
use and b) actual behaviour in relation to substance use. 
Data can be collected at baseline with the target group and 
used to design interventions and for follow-up comparisons. 
Data from published studies, for example, the ESPAD, 
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HBSC and NACD surveys2 can also be used to challenge 
misperceptions about the prevalence and attitudes towards 
substance use among young people. 
How is the social norms approach delivered? 
‘Social norms interventions have typically come in one 
of two forms: social marketing or individual normative 
feedback. Social marketing approaches rely on universal, 
mass communication methods for educating students 
regarding actual [substance use] behaviours... . Individual 
normative feedback is personalised and may provide a more 
relevant and powerful intervention.’3 
What is the evidence that the social norms approach can 
be effective? 
According to McAlaney and colleagues,
The goal of [global social norms] campaigns is 
to disseminate the accurate substance use norms 
to the target population, such as “Most (73%) 
students at [college name] have no more than four 
alcoholic drinks on a night out.” This approach 
was fi rst implemented in 1989 at Northern Illinois 
University, which reported a drop in rates of heavy 
drinking from 43% to 25% over a 9-year period, 
accompanied by a reduction in the misperception of 
heavy drinking among peers from 70% to 33%. 
Moreira and colleagues undertook a Cochrane systematic 
review to determine whether social norms feedback 
reduces alcohol misuse among university or college 
students. The review included 22 controlled trials involving 
7,275 participants randomly assigned to a social norms 
intervention group or to a control group (no social norms 
intervention – assessment only, questionnaire used to 
measure alcohol consumption or alternative educational 
or psychosocial intervention). The following outcomes 
were observed: 
 ■ Alcohol-related problems; signifi cant reduction 
with web/computer feedback in three studies 
(278 participants);
 ■ Peak Blood Alcohol Content (BAC); signifi cant 
reduction with web/computer feedback in two 
studies (198 participants); 
 ■ Drinking frequency; signifi cant reduction with web/
computer feedback in two studies (243 participants) 
and individual face-to-face feedback with two studies 
(217 participants); 
 ■ Drinking quantity; signifi cant reduction with web/
computer feedback in fi ve studies (556 participants) 
and group face-to-face feedback with three studies 
(173) participants;
 ■ Binge drinking; signifi cant reduction with web/computer 
feedback in one study (80 participants), individual 
face-to-face feedback in three studies (278 participants) 
and group face-to-face feedback in four studies 
(264 participants);
 ■ Drinking norms; signifi cant reduction with web/
computer feedback in three studies (312 participants). 
In summarising the key fi ndings of the Cochrane review, the 
authors make the following points: 
This systematic review based on 22 trials enrolling 
7,275 participants shows that a social norms 
intervention delivered by web or computer or via 
individual face-to-face sessions (for some outcomes) 
is more effective than a control intervention, typically 
consisting of a leafl et with drinking related advice, 
for reduction of alcohol misuse in college or 
university students. Signifi cant effects were more 
apparent for short term outcomes (up to three 
months). However, there was some evidence of 
effect continuing through to medium-term follow-up 
from four to sixteen months, particularly for web/
computer feedback. 
Authors’ conclusion on the implications for practice
Overall, this systematic review suggests that individual and 
personalised normative interventions over the immediate 
and medium term appear to reduce alcohol use, misuse and 
related problems amongst university or college students. The 
use of social norms interventions should also be considered 
for use and study in other settings since they have the 
potential to be a very cost-effective intervention for reducing 
alcohol use and related harms. The use of new technologies, 
such as computer or web/computer delivered interventions, 
could be a successful and cost-effective method for 
providing normative feedback. 
Limitations of the Cochrane review
Small sample sizes in many of the studies
Can the social norms approach be transferred to 
alternative settings and target groups? 
The evidence to date suggests that the social norms 
approach has been mainly delivered to university and 
college students in the USA. However, this is changing and, 
as pointed out by McAlaney and colleagues, the approach 
has been used to change an array of behaviours e.g. 
sunscreen use, rumour spreading in high-school and towel 
re-use in hotels. In addition, Moreira and colleagues state 
that social norms should be considered for other settings. 
(Martin Keane)
1. McAlaney J, Bewick B and Hughes C (2011) The 
international development of the ‘social norms’ 
approach to drug education and prevention. Drugs: 
education, prevention and policy, 18(2): 81–89.
2. ESPAD (European School Survey Project on Alcohol 
and other Drugs); HBSC (Health Behaviour in School-
aged Children); NACD (National Advisory Committee 
on Drugs). 
3. Moreira MT, Smith LA and Foxcroft D (2009) Social 
norms interventions to reduce alcohol misuse in 
University or College students. Cochrane Database 
of Systematic Reviews, Issue 3. Art. No.: CD006748. 
DOI: 10.1002/14651858.CD006748.pub2. http://
onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/
CD006748/pdf_fs.html. 
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Maternal and neonatal health among 
opiate users
Two recent papers present the results of studies on the 
health of women who had been prescribed methadone for 
the treatment of opiate dependence and their infants born 
in the Coombe Women and Infants University Hospital in 
Dublin. The fi rst paper reported that the services of a liaison 
midwife were required to encourage pregnant women 
with opiate dependence to attend drug and maternity 
services regularly, and to liaise between professionals in both 
services. The second paper reported that the outcomes for 
mothers prescribed methadone and their new infants were 
not as good as those for other mothers and infants attending 
the maternity service. The key issues addressed in the papers 
are presented below. 
Drug use in pregnancy: challenges for health 
care workers
This comparative study examined maternal and neonatal 
outcomes for pregnant women from the case load of a drug 
liaison midwife over the period 2002–2007,1 compared with 
outcomes in a similar study carried out in 1999–2000.2 
Of 524 women who attended the drug liaison midwife 
in the six-year period, 436 delivered a live baby after 32 
weeks’ gestation who did not have congenital anomalies. 
All women were engaged with drug treatment and 
obstetric services. 
The 2002–2007 cohort was older (average age 25.9 years, 
range 17–32 years) and had marginally more pregnancies 
than the 1999–2000 cohort (average age 23.8 years, range 
16–41 years). The 2002–2007 cohort attended their fi rst 
antenatal visit earlier (at 15 weeks gestation) than the 1999 
to 2000 cohort (at 18 weeks). Three-fi fths of both cohorts 
attended fi ve or more antenatal visits (satisfactory antenatal 
attendance). There were no maternal deaths among either 
cohort. 
The average age at fi rst heroin use was higher by one year 
(at 18 years) in the later cohort when compared to the 
earlier cohort. Opiate stability was marginally lower (50%) 
in the later cohort than in the earlier cohort (53%). Tobacco 
(91%), benzodiazepines (66%), alcohol (percentage 
not reported) and cocaine (71%) were commonly used 
alongside heroin by the later cohort. The rates of tobacco 
and benzodiazepine use were marginally lower, and the rate 
of cocaine use was higher, in the later cohort. 
A very high proportion (93%) of the 2002–2007 cohort was 
taking prescribed methadone, compared to the 1999–2000 
cohort (75%). The average dose of methadone at delivery 
was higher for the later cohort (60mg) than for the earlier 
cohort (39 mg). The average gestation at delivery was 
38 weeks for both cohorts. The average birth weight was 
higher by 66g in the later cohort. The percentage of babies 
requiring admission to the special care baby unit had 
increased from 42% in the earlier cohort to 56% in the later 
cohort. The proportion of babies requiring treatment for 
neonatal abstinence syndrome was considerably higher in 
the later cohort (45%) than in the earlier cohort (29%). The 
babies’ average length of stay in the special care baby unit 
increased by over 2 days in the later cohort when compared 
to the earlier cohort. 
The data indicate that opiate-dependent pregnant women 
and their infants are a very vulnerable group and require 
special care at both drug treatment and maternity hospitals. 
Methadone and perinatal outcomes: a retrospective 
cohort study 
This study examined the relationship between methadone 
maintenance treatment and maternal characteristics, 
perinatal outcomes as well as neonatal abstinence 
syndrome.3 This was a retrospective cohort study of 61,030 
singleton births at a large maternity hospital in the period 
2000–2007 based on antenatal, delivery and postnatal 
records and the Central Treatment List (of clients prescribed 
methadone).
Of the 61,030 singleton births, 618 (1%) were to 
women who were prescribed methadone at delivery. 
Methadone-exposed women were more likely to be 
younger, unemployed, Irish, unmarried, have had previous 
pregnancies, have an unplanned pregnancy, to book 
antenatal care later than 20 weeks into pregnancy, to be 
current smokers and to drink alcohol before pregnancy. 
In addition, and as expected, a higher proportion of 
methadone-exposed women were likely to test positive for 
hepatitis B, hepatitis C and HIV when compared to non-
exposed women (Table 1). 
Table 1 Blood-borne viral status among the study 
populations by exposure to methadone
Exposed to 
methadone* Non-exposed*
Hepatitis B positive 
serological status 20 (3.5%) 326 (1.0%)
Hepatitis C positive 
serological status 275 (48.2%) 193 (0.6%)
HIV positive 35 (5.8%) 171 (0.3%)
* The total number tested in each group is not presented 
in the paper. 
Methadone exposure was associated with an increased 
risk of very preterm birth (before 32 weeks’ gestation), 
being small for gestational age (below the 10th percentile), 
admission to the neonatal unit, and diagnosis of a major 
congenital anomaly. There were four cases of Pierre 
Robin sequence among 618 methadone–exposed babies, 
compared to eight cases in 60,412 non-exposed infants. 
Although not statistically signifi cant, the proportion of 
deaths within the fi rst six weeks of birth was three times 
higher among the methadone-exposed group (2.4%) than 
the non-exposed group (0.8%). 
There was a dose–response relationship between methadone 
and neonatal abstinence syndrome. As the dose of 
methadone increased so did the incidence of neonatal 
abstinence syndrome (Table2). Preterm birth and small 
gestational age also predicted the presence of neonatal 
abstinence syndrome. 
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Table 2 Methadone dose and its relationship with neonatal abstinence syndrome (n=615)
Neonatal abstinence syndrome
Methadone dose in mg Present Absent Adjusted odds ratios (95% CI)*
<21 19 (23.8) 61  (76.2) 1
21–50 73 (33.3) 146 (66.7) 0.9–3.5
51–80 117 (47.4) 130 (52.6) 1.6–6.53
81–100 26 (48.1) 28 (51.8) 1.3–7.5
>100 11 (73.3) 4 (26.7) 2.5–48.0
*Adjusted for preterm birth, gestational age, gender, maternal smoking during pregnancy and alcohol use before pregnancy
Maternal and neonatal health among opiate users  (continued)
After controlling for known adverse socio-demographic 
factors, methadone exposure was found to be associated 
with an increased risk of adverse perinatal outcomes. 
Methadone dose at delivery was one of the important 
determinants of neonatal abstinence syndrome.
(Jean Long)
1. Carmody D, Geoghegan N, Sheppard R, Keenan E and 
O'Connell M (2011) Drug use in pregnancy: challenges 
for health care workers. MIDIRS Midwifery Digest, 20(4): 
447–450.
2. Scully M, Geoghegan N, Corcoran P, Tiernan M and 
Keenan E (2004) Specialized drug liaison midwife 
services for pregnant opioid dependent women in 
Dublin, Ireland. Journal of Substance Abuse Treatment, 
26(1): 27–33.
3. Cleary BJ, Donnelly JM, Strawbridge JD, Gallagher PJ, 
Fahey T, White MJ, Murphy DJ. (2011) Methadone 
and perinatal outcomes: a retrospective cohort study. 
American Journal of Obstetrics and Gynecology, 204(2): 
139.e1–9. 
Review of treatment for over-the-
counter opiate misuse
There is a limited amount of detailed information in Ireland 
and internationally on the misuse of over-the-counter (OTC) 
opiates. Researchers at St Patrick’s University Hospital have 
examined the clinical profi les, treatment and prevalence of 
patients admitted in a 12-month period with a diagnosis of 
OTC opiate abuse.1 
All inpatient records between 1 April 2007 and 30 April 
2008 were retrospectively reviewed, and 20 patients were 
identifi ed as having a diagnosis of either harmful use of OTC 
opiate or dependency. These patients represented 0.6% 
of all patients admitted during that period, and 4% of all 
patients diagnosed with mental or behavioural disorder due 
to psychoactive substances. Of the 20 patients, 70% had a 
diagnosis of opiate dependency and 30% of harmful opiate 
use. In addition, all but one (95%) had a diagnosis of co-
morbid psychiatric illness. Codeine was the opiate misused 
in all 20 cases, and all cases reported using a combination-
type OTC opiate, that is, codeine with paracetamol (e.g. 
Solapdeine) or codeine with ibuprofen (e.g. Nurofen Plus). 
Fifteen patients received treatment for opiate withdrawal. 
Some of the other main fi ndings of the study were:
• The mean age of the 20 patients studied was 
49 years;
• 13 were female;
• 13 had a history of harmful use of or dependency 
on alcohol;
• 8 had a history of harmful use of or dependency 
on benzodiazepines;
• 16 reported daily use;
• 4 reported chronic pain;
• 7 relapsed within six months;
• 15 obtained the drug over the counter;
• 5 obtained the drug over the internet.
Although the numbers in the study were small, the high 
rates of polysubstance misuse and co-morbid psychiatric 
illness among the cases reviewed are consistent with the 
fi ndings of similar research internationally. The authors note 
with concern that the average reported amount of codeine 
taken daily was high (261mg), and suggest that this is likely 
to have been an underestimation. They point out that, to 
ingest such a large amount of codeine in the form of an OTC 
product, an individual would have to take correspondingly 
large daily doses of the combination compounds, usually 
paracetamol or ibuprofen, which greatly increased the risk 
of side-effects or overdose from both products. The authors 
suggest preventative measures, such as reducing the 
number of tablets per pack and placing an additional 
health warning on packaging. They state that any move to 
make OTC opiates prescription-only needs to be carefully 
considered, taking account of the increase in pressure on 
GPs and the reduction in patient autonomy that such a 
move might cause.
In May 2010 the Pharmaceutical Society of Ireland published 
guidelines2 on the safe dispensing of OTC opiate products; 
these products can now be dispensed only under the 
supervision of a pharmacist. 
(Suzi Lyons)
1. Thekiso T and Farren C (2010) ‘Over the counter’ (OTC) 
opiate abuse treatment. Irish Journal of Psychological 
Medicine, 27(4): 189–191.
2. Pharmaceutical Society of Ireland (2010) Non-prescription 
medicinal products containing codeine: guidance 
for pharmacists on safe supply to patients. Dublin: 
Pharmaceutical Society of Ireland. Available at www.
drugsandalcohol.ie/13191.
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Mental illness and alcohol and other 
drug use
Substance dependence and other mental illnesses co-exist 
in a proportion of patients attending health services and 
recent research has attempted to estimate and describe the 
phenomenon. Two such studies are described in this article. 
Co-morbid drug use or psychiatric diagnosis among 
alcohol-dependent patients
Lyne and colleagues reviewed the records of patients 
presenting with co-morbid psychiatric diagnoses and drug 
use at a 12-bed alcohol treatment unit in a psychiatric 
teaching hospital in Dublin between 1995 and 2006.1 
Patients were included if they were aged 44 years or under, 
remained in hospital for more than 28 days, and had a 
diagnosis of alcohol dependence. 
The review of 465 records revealed that 38.9% patients 
had used drugs other than alcohol during their life and 
34.2% had a documented history of a co-morbid psychiatric 
diagnosis. Cannabis (26.4%), cocaine (17.1%), and ecstasy 
(12.5%) were the most common substances reported. 
Just under 10% reported use of benzodiazepines or other 
sedatives and just under 6% had used heroin. The disease-
specifi c rates were: 25.3% had a depressive disorder; 3.9% 
an anxiety disorder; 2.8% a bipolar affective disorder and 
2.2% a psychotic disorder. A small proportion (3.7%) of 
patients had two or more psychiatric diagnoses alongside 
their alcohol dependence. Forty-eight (10.3%) patients had 
a documented history of deliberate self-harm, of whom 29 
had a psychiatric diagnosis as well as alcohol dependence. 
The median age of the study population was 37 years 
and the age range was 17–44 years. Just over three-fi fths 
(61.1%) of patients were men; 203 (44.3%) of the patients 
were never married; and 38 (8.3%) were separated or 
divorced. The proportions of women with a history of 
depressive disorder, eating disorder and deliberate self-harm 
were signifi cantly higher than those for men. The proportion 
of men with psychotic disorder was marginally higher than 
that of women. Deliberate self-harm was associated with 
lifetime drug (excluding alcohol) use. Ecstasy users were 
more likely to have a diagnosis of depression. 
Cannabis use and non-clinical dimensions of psychosis in 
university students presenting to a student health clinic
Skinner and colleagues explored the relationship between 
cannabis use and self-reported dimensions of psychosis in a 
population of university students presenting for any reason 
to primary care.2
Fifteen thousand students were enrolled in undergraduate 
or postgraduate courses at the National University of 
Ireland, Galway, in 2008. One thousand and forty-nine (7%) 
students attended the Student Health Unit between April 
and October of that year and these completed self-report 
questionnaires on:
 ■ demographic profi le; 
 ■ history of mental illness; 
 ■ alcohol and other drug misuse; 
 ■ non-clinical dimensions of psychosis [Community 
Assessment of Psychic Experiences (CAPE)]; 
 ■ anxiety and depression [Hospital Anxiety and Depression 
Scale (HADS)]. 
The respondents may not be representative of the third-level 
student population. The average age of the respondents 
was 21.2 years (range 17–54); 82% were women; 94% 
were Irish; and 96% were single. Sixteen per cent sought 
professional help for emotional or psychiatric problems; 23% 
reported a family history of mental illness; and almost 5% 
reported a family history of psychotic illness. 
Respondents reported drinking an average of 9.4 units 
(range 0–120) of alcohol per week and an average of 5.9 
units (range 0–35) per sitting. Forty per cent (423) had 
smoked cannabis at least once in their life, of whom 327 
reported use between 1 and 30 times and 86 reported use 
30 or more times. The average age at fi rst use of cannabis 
was almost 17 years (range 10–40). The rates of lifetime use 
of other drugs were: ecstasy 6.9%, cocaine 5.8%, magic 
mushrooms 5.1%, LSD 2.1% and heroin 0.1%. 
Twenty one per cent had HADS scores of between 8 and 10 
(borderline abnormal level) on the anxiety subscale and 15% 
had scores of 11 or above (abnormal level). Just under 3% 
reported borderline abnormal level on the depressive subscale 
and 1% reported abnormal level. The average weighted CAPE 
frequency score for negative symptoms was 1.57 (range 
1–4), and for positive symptoms 1.29 (range 1–3). 
The higher HADS anxiety scores were associated with 
a personal history of mental illness, a family history of 
psychiatric disorder and being female. The higher HADS 
depression scores were associated with a personal history of 
mental illness. 
The CAPE positive psychotic symptom scores were 
associated with: personal history of mental illness, family 
history of psychiatric disorder, younger respondents and 
men. The CAPE negative psychotic symptom scores were 
associated with: personal history of mental illness and 
family history of psychiatric disorder. The CAPE depressive 
symptom scores were associated with: a personal history of 
mental illness, a family history of psychiatric disorder and 
being female.
After controlling for the effects of personal history of mental 
illness, family history of psychiatric disorder, age and 
gender, the CAPE positive and negative psychotic symptom 
scores were associated with high frequency cannabis use. 
In addition, the CAPE negative psychotic symptom scores 
and depressive symptom scores were associated with low 
frequency cannabis use. 
After further controlling for frequency of cannabis use, it 
was found that the earlier the age at which a person 
commenced cannabis use the more positive psychotic 
symptoms they experienced. 
These fi ndings support the hypotheses that cannabis use 
increases the risk of developing psychotic symptoms and 
that this risk is further increased in individuals who use 
cannabis more heavily and commence use at a younger age.
(Jean Long)
1. Lyne J, O Donoghue B, Clancy M and O’Gara C (2011) 
Comorbid psychiatric diagnoses among individuals 
presenting to an addiction treatment program for 
alcohol dependence. Substance Use & Misuse, 46(4): 
351–358.
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Infectious diseases update
A number of recently published studies examining 
different aspects of infectious diseases and drug use are 
summarised below.
Substance use among HIV patients
The authors compared the characteristics and behaviours 
of people with HIV living in Ireland with those in Australia.1 
The data were collected between June and December 2005 
and the participants were asked about tobacco, alcohol 
and other drug use. The average age of the respondents in 
Ireland was 36.2 years, and in Australia 45.3 years. Sixty-
seven per cent of the study group in Ireland were men, while 
98% of those in Australia were men. Forty-seven per cent of 
the participants in Ireland were Irish and 42% were African. 
Two thirds of the participants in Australia were Australian 
and 16% were New Zealanders. Forty-two per cent of 
participants in Ireland reported using recreational drugs 
at some point in their life; seven respondents reported 
ever injecting, and four reported a history of drug 
dependence. Fifty-four per cent reported smoking tobacco 
at some point in their life. Seventy-two per cent drank 
alcohol at some point in their life, of whom 9% reported a 
history of alcohol dependence. 
Table 1 Substance misuse among HIV patients
Ireland Australia
n % n %
Recreational drugs
Current use 12 13 61 41
Past use 28 29 46 64
Admits addiction 7 18 18 18
Admits injecting drug use 4 10 18 18
Tobacco
Current use 34 37 55 37
Past use 16 17 38 26
Never used 42 46 54 37
Alcohol
Current use 49 52 107 77
Past use 29 30 27 19
Never used 18 19 6 4
Admits addiction 7 9 11 8
MRSA and MSSA among attendees at a Dublin 
methadone clinic
Ninety-six of 183 clients attending methadone treatment at 
the Drug Treatment Centre Board in Dublin were randomly 
selected to complete a 12-item questionnaire, and to 
provide nasal swabs to be tested for meticillin resitant 
Staphylococcus aureus (MRSA) and meticillin sensitive 
Staphylococcus aureus (MSSA) and blood samples for 
viral analysis.2 
Of the 96 nasal swab specimens submitted for culture and 
identifi cation, 3.1% grew MRSA and 25% grew MSSA. The 
serological analysis revealed that 73% of the clients were 
hepatitis C positive and 12% were HIV positive.
Seventy three per cent of the sample were men. Twenty-
seven per cent of the clients had been in prison in the year 
prior to the survey and 86% had been in prison at least once 
in their life. One quarter had been homeless at some stage in 
the preceding 12 months and 27% lived alone. 
Seventeen per cent had snorted cocaine in the year prior to 
the survey and 24% had injected it. Forty- eight per cent had 
injected heroin in the 12 months prior to the survey, and 
53% had injected either heroin or cocaine. All injectors had 
attended needle-exchange services at least once in the 12 
months prior to data collection; only 7% had shared needles, 
while 18% had shared other injecting equipment. Twenty-
eight per cent reported at least one soft-tissue abscess in the 
past year, 71% had had one or more courses of antibiotics, 
and 40% had had at least one hospital admission. 
As the prevalence of MRSA was low and the sample size very 
small, it was not possible to identify factors associated with 
MRSA carriage among those in methadone treatment. The 
prevalence of MRSA in the opiate-dependent population in 
Dublin is lower than that in Brighton (49%) and Vancouver 
(19%) but higher than that in Italy (1.1%). 
Hepatitis C management: the challenge of dropout
This study examined all referrals made to an urban tertiary 
care liver centre for hepatitis C virus (HCV) management, 
tracked subsequent progress and identifi ed the dropout rate 
at the different stages.3 The authors completed a cross-
sectional retrospective review to examine HCV referrals 
received between 2000 and 2007. The demographic, clinical 
and treatment data were extracted from medical charts and 
the hospital information system.
A total of 588 individuals and 742 cases were referred for 
management of their hepatitis C. Sixty-seven per cent of 
referrals were men and the average age was 33.3 years. 
Three quarters (74%) of cases were injecting drug users. 
Eighty-three per cent of cases were Irish. Fifty-seven per cent 
of cases were referred by their general practitioner. Other 
sources of referral were hospital, drug treatment centres, 
prisons and asylum centres. Of the 742 referrals received, 
141 (19%) failed to attend their initial appointment, 180 
(24%) dropped out from early outpatient management, 
29 (4%) failed to attend for liver biopsy and 81 (11%) 
did not attend subsequent outpatient follow-up. In 
total, 451 (61%) dropouts occurred. In those treated, a 
sustained viral response rate (successful treatment rate) 
of 74% was observed. The number and proportion of 
patients who experienced viral clearance varied with 
genotype, specifi cally, genotype 1 18/30 (60%); genotype 
2. Skinner R, and Conlon L, Gibbons D and McDonald C 
(2011) Cannabis use and non-clinical dimensions of 
psychosis in university students presenting to primary 
care. Acta Psychiatrica Scandinavica, 123(1): 21–27.
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2 4/5 (80%); genotype 3 40/49 (82%). Those with a 
history of injection drug use were more likely to drop 
out immediately after the referral, dropout from early 
outpatient management and dropout over entire span of 
disease management than their non-injecting counterparts. 
Men were more likely (P<0.05) to drop out of disease 
management than women. Eight individuals died during the 
study period.
The authors report that an ‘exceptionally high rate of 
dropout exists’ among those attending services to monitor 
and manage hepatitis C in injecting drug users, particularly 
in the early stages of service delivery. The study fi ndings have 
led to the development of innovative approaches helping to 
optimize hepatitis C management in this population, such 
as texting reminders and using a change model to improve 
engagement and compliance with behaviour and treatment.
Hepatitis C virus in primary care: survey of nurses’ 
attitudes to caring 
This study measured the knowledge of and attitudes 
towards hepatitis C among 560 nurses working in general 
practice, public health and addiction, and identifi ed the 
source of their knowledge.4 The researchers completed a 
cross-sectional survey in 2006 with the nurses in the three 
categories of primary care through a postal questionnaire 
in one region of Ireland. The questionnaire contained 
fi ve sections: demographic, work profi le, knowledge, 
attitude and education. The questions were validated 
and pilot tested. The total number of primary care nurses 
working in the region was 981 and 560 (57%) completed a 
questionnaire. The response rates varied by type of 
nursing specialism: general practice was 57% (126), public 
health 55% (385) and addiction services 83% (49). The 
attitudes of the nurses towards hepatitis C are not presented 
in this paper. 
Almost all (98%) of the nurses were female, and their 
average age was 43 years. Nurses in the addiction services 
were younger than those in general practice or in public 
health services. The nurses’ qualifi cations ranged from 
certifi cate (25%) to post graduate degree (4%) level. Fifty-
fi ve per cent were qualifi ed to diploma or higher diploma 
level and 15% were qualifi ed to at least degree level. Nurses 
in the addiction and in the public health services had higher 
qualifi cations than those in general practice. Nurses working 
in the public health service had longer service than those in 
addiction or general practice. Addiction nurses were more 
likely to work full time. 
Eighteen per cent had a personal friend or relative who had 
hepatitis C. Thirty-nine per cent of respondents reported 
having professional contact with people with hepatitis C. As 
expected, nurses in addiction services had more professional 
dealings with people with hepatitis C (96%) compared 
to nurses in public health (30%) or in general practice 
(44%). According to the authors, 90% of addiction service 
nurses provided information on the dangers of alcohol, the 
benefi ts of hepatitis A and B vaccination, dietary intake and 
transmission of the virus, while only 30% of nurses in public 
health provided advice on the dangers of alcohol, and 11% 
of the same cohort on the benefi ts of hepatitis vaccination. 
The advice provided by practice nurses is not reported. 
Only 22% of nurses had received formal training on hepatitis 
C. Not surprisingly, a higher proportion (86%) of nurses 
working in the addiction services received training on 
hepatitis C, compared to the proportions working in public 
health (13%) or general practice (16%). Ninety-six per 
cent of nurses working in the addiction services reported 
that they were well informed about hepatitis C, while only 
20% of practices nurses and 21% of public health nurses 
reported the same. The respondents were asked to identify 
21 statements about hepatitis C as true or false. Though the 
nurses working in addiction services had good knowledge 
about hepatitis C, there were four areas where 25% or more 
provided an incorrect answer, and these were:
• Hepatitis C can be spread through close personal 
contact such as kissing; this is false but 25% of the 
nurses said it was true
• Hepatitis C is commonly spread through sexual 
transmission; this is false
• Most people who get hepatitis C will die prematurely 
because of the infection; this is false
• More than 50% of pregnant women with HCV will 
infect their children; this is false
The level of knowledge among the public health and 
practice nurses was less than desirable, with at least 12 areas 
where 25% of the nurses provided an incorrect answer. Four 
of the areas were those cited above and the other eight 
areas were: 
• People with hepatitis C should be restricted from 
working in the food industry; this is false but 25% of 
nurses working in public health and general practice 
said it was true
• Hepatitis C is a mutation of the hepatitis B virus; this 
is false
• There is no pharmaceutical treatment for hepatitis C; 
this is false
• HIV is easier to catch than hepatitis C; this is false
• Once you have hepatitis C you cannot get it again 
because you are immune; this is false
• There is only one genotype of hepatitis C virus; this 
is false
• Hepatitis C is associated with an increased risk of 
liver cancer; this is true but 25% of nurses working in 
public health and general practice said it was false
• People can have the hepatitis C virus without being 
currently infected with the virus; this is true
The authors calculated mean knowledge-level scores for 
each group of nurses; the mean score for addiction nurses 
was 22.5, for nurses working in public health 16 and for 
practice nurses 16.9. The overall mean score was 16.7. 
Nurses were most likely to have better knowledge about 
hepatitis C if they were younger, educated to degree level or 
above, attended a formal training course, personally knew 
someone with hepatitis C, had professional contact with 
patients with hepatitis C, or considered that they themselves 
were well-informed about hepatitis C. 
Nurses working in public health services and general practice 
require formal training in hepatitis C care and management. 
Nurses in the addiction services need to update their 
knowledge in four areas. 
(Compiled by Jean Long)
drugnet 
IRELAND
23
1. O'Connor MB, O'Connor C, Saunders SA, Sheehan C, 
Murphy E, Horgan M et al. (2010) Substance use among 
HIV patients. Irish Journal of Medical Science, 179(3): 
467–468.
2. Somers CJ, Bridgeman J and Keenan E (2010) Nasal 
carriage prevalence of meticillin resitant (MRSA) and 
meticillin sensitive (MSSA) Staphylococcus aureus for 
subjects attending a Dublin methadone clinic. Journal of 
Infection, 60(6): 494–496.
3. Lowry DJ, Ryan JD Ullah N, Barry T and Crowe J (2011) 
Hepatitis C management: the challenge of dropout 
associated with male sex and injection drug use. 
European Journal of Gastroenterology & Hepatology, 23(1): 
32–40.
4. Frazer K, Glacken M, Coughlan B, Staines A and Daly L 
(2011) Hepatitis C virus in primary care: survey of nurses’ 
attitudes to caring. Journal of Advanced Nursing, 67(3): 
598–608.
Infectious diseases update  (continued)
From Drugnet Europe 
Over 40 new drugs reported in 2010
Cited from article by Roumen Sedefov and Ana Gallegos in 
Drugnet Europe, No. 74, April–June 2011
According to the EMCDDA–Europol 2010 report on new 
drugs entering the European market,1 41 new psychoactive 
substances were offi cially notifi ed for the fi rst time to the 
two agencies in 2010. This represents the largest number 
of substances ever reported in a single year, considerably 
up on 2009 (24 substances) and 2008 (13 substances). The 
full list of substances notifi ed shows a ‘rather diverse’ group, 
including: synthetic cannabinoids, synthetic cathinones, 
synthetic derivatives of well-established drugs as well as one 
plant-based substance (arecoline).
The report gives an account of the risk assessment of the 
synthetic cathinone derivative, mephedrone, which led 
to the decision for Europe-wide controls on the drug in 
December 2010. A further 15 synthetic cathinone derivatives 
were detected during the year. Also documented is the 
fi rst-time appearance of derivatives of two established drugs: 
ketamine and PCP (phencyclidine). 
Commenting on this year’s fi ndings, EMCDDA Director 
Wolfgang Götz said: ‘Given the speed at which new 
developments occur in this area, it is important to anticipate 
future challenges. While our early-warning system has 
recently upped its operational capacity to react rapidly to 
new substances and products identifi ed, it currently lacks 
the ability to anticipate emerging threats. This could be 
addressed by actively purchasing, synthesising and studying 
new compounds and by improving capacity for investigative 
forensic analysis and research at European level.’
1. EMCDDA–Europol (2011) EMCDDA–Europol 2010 
annual report on the implementation of Council Decision 
2005/387/JHA. Lisbon: EMCDDA, www.emcdda.europa.
eu/publications/implementation-reports/2010
Opioid substitution treatment: the role of general 
practitioners
Cited from article by Allesandro Pirona in Drugnet Europe, 
No. 74, April–June 2011
General practitioners are becoming an increasingly 
important provider of drug treatment services in Europe and 
are helping to reduce inequalities in the accessibility and 
availability of opioid substitution treatment (OST). GPs now 
provide OST to heroin dependent users in 14 EU countries, 
usually under shared care arrangements with specialised 
treatment centres. It is estimated that around a third of the 
estimated 670 000 clients in OST in Europe receive their 
treatment through GPs.
While specialist drug treatment services remain the 
EMCDDA’s main data suppliers in this area, GPs and other 
service providers can be a key additional information source, 
helping to improve reporting on overall treatment provision 
in Europe. Such information is pivotal in assessing the 
availability and accessibility to effective treatment as well as 
gauging the unmet needs of drug users.
Under its 2011 work programme objective ‘to develop and 
explore potential new data sources on drug treatment and 
harm reduction’, the EMCDDA is investigating strategies for 
collecting treatment data from GPs. It is also facilitating the 
exchange of experience between GPs and scientists in the 
EU regarding the benefi ts of GP involvement in this type 
of treatment (e.g. client health management, continuity of 
care) and the challenges in current medical practice (e.g. 
managing polydrug use, diversion of medications).1 
1. European exchange on the practice and current issues 
in opioid substitution treatment in general practitioners’ 
settings. www.emcdda.europa.eu/html.cfm/
index2062EN.html
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Drugs in focus – policy brieﬁ ng
Khat use in Europe: implications for European policy
(Cited from Drugs in focus, No. 21, 1st Issue, 2011)
Khat refers to the young and tender leaves and shoots of 
the khat tree (Catha edulis) cultivated in the highlands 
of the Horn of Africa, Southern Arabia and along the East 
African coast. It contains stimulant substances that have 
amphetamine-like properties. In their pure forms, they are 
internationally controlled substances, but the leaves are not. 
Excessive consumption can lead to dependence. It may also 
result in somatic and mental health hazards in otherwise 
healthy individuals. In Europe, khat is controlled in some, but 
not all, countries. This has resulted in both legitimate and 
criminal transportation networks. Khat is mainly consumed 
by fi rst generation immigrants from sub-Saharan Africa, 
among whom it is a contested topic. Over the last three 
decades, khat has become a major source of employment, 
income and revenues in producing countries.
Conclusions and policy considerations
 ■ The potential for the crossover of khat to the wider drug 
market appears limited.
 ■ Khat consumption may lead to health and social 
problems. European health professionals and social 
workers need to be able to identify khat-related 
harms and have strategies in place to protect 
vulnerable user groups.
 ■ European khat markets appear to be growing but 
data sources are weak, pointing to a need to improve 
monitoring. 
 ■ Development and drug control policies for khat-
producing countries require co-ordination and an 
awareness of the potential impact of European control 
measures.
 ■ Khat is primarily used by migrant communities in 
Europe. These communities need to be better informed 
about its potential health, social and legal consequences. 
 ■ The number of khat users in Europe appears to be 
growing, yet the scale and nature of the problem is 
poorly understood. Research studies are therefore 
required to better assess the market for the drug, 
evolving patterns of use, as well as the extent of any 
socio-economic and health consequences.
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In brief
On 27 October 2010 the New Zealand Law Commission 
published its report Compulsory treatment for substance 
dependence. It concludes that compulsory treatment for 
alcohol and drug dependence is only justifi ed when a 
person’s dependence has seriously impaired his or her 
capacity to make choices about ongoing substance use and 
personal welfare; care and treatment is necessary to protect 
the person from signifi cant harm; no other less restrictive 
means are reasonably available for dealing with the person; 
the person is likely to benefi t from treatment; and the person 
has refused treatment. The report includes proposals to 
make the existing law relating to compulsory treatment 
more user-friendly while also providing greater safeguards 
for people forced to undergo compulsory treatment. 
www.lawcom.govt.nz 
On 13 December 2010 the British–Irish Council held its 
15th summit meeting, attended by senior political leaders 
from the eight member administrations, including Ireland. 
It received an update on the work of the Misuse of Drugs 
workstream during 2010, which included meetings on 
the policies of the eight administrations in tackling alcohol 
misuse, substance misuse in prisons, and headshops, as 
well as new directions for drug and alcohol policy and 
community action in dealing with drugs, alcohol and anti-
social disorder. In 2011 the group will discuss the new UK 
National Drugs Strategy. www.gov.je/BritishIrishCouncil 
On 24 January 2011 the Children’s Rights Alliance 
released its third Children’s report card 2011. Alcohol 
gets an ‘F’ grade again, no change from last year. The 
assessors comment that although progress had been 
made in prioritising and intensifying measures to tackle 
alcohol misuse among young people, and doubling the 
penalties for all related statutory offences, the focus has 
been wrong. Greater emphasis is needed on enforcement 
and implementing evidence-based policy solutions. 
www.childrensrights.ie 
On 21 February 2011 STAR awards, which recognise and 
celebrate collaborative work undertaken in adult learning 
initiatives in local communities, were awarded to two 
drug-related adult learning projects. The School of Applied 
Social Science in UCD in conjunction with Merchants Quay 
Ireland (MQI), An Cosan (Tallaght) and Urrus (Ballymun) 
were the nationwide winners for the Partnership Education 
Initiative in Drug Prevention Education and Research 
Capacity, i.e. two diploma programmes provided through 
local service providers. Soilse, whose participants all come 
from a drug addiction background, topped the Dublin 
region for its Service User Involvement (SUI) programme. 
Highly commended in the Dublin region was RADE Ltd 
(Recovery through Art, Drama and Education), 
which engages recovering drug users in arts activities. 
www.adultlearnersfestival.com/starawards
On 28 February 2011 the Children’s Rights Alliance 
published Ten years on: did the National Children’s Strategy 
deliver on its promises? It reports progress on Action 40 to 
expand specialist drug treatment for under-18s, although 
‘the impact on children’s lives is unknown as impact of 
funding on services is unclear’. Progress is also reported on 
Action 78 ‘to provide an adequate emergency response to 
young homeless people (including day service, education 
and training, drug treatment)’. However, the supports 
available and responses to homelessness among children 
are deemed ‘still patchy and ad hoc across the country’. 
www.childrensrights.ie
On 23 March 2011 the World Health Organization (WHO) 
launched the ASSIST package of screening and brief 
interventions to help health professionals detect and respond 
to alcohol, tobacco and other psychoactive substance 
use. It comprises a brief questionnaire, a guide for health 
professionals on how to use the questionnaire in detecting 
and responding to substance use and a self-help manual 
for cutting down or stopping substance use. It is WHO’s 
response to the growing demand for guidance on how to 
manage substance use problems in non-specialist health care 
settings. www.who.int/topics/substance_abuse/en 
In April 2011 the results of the fi rst Your Dublin, Your Voice 
survey were published. An opinion panel of almost 2,300 
members has been formed to fi nd out their views on living, 
working and studying in the city region. The fi rst iteration 
of the survey was undertaken in October–December 2010. 
Respondents were asked to describe unprompted and 
in their own words the worst thing about Dublin. Over 
2,200 comments showed a very strong consensus, with 
over one in three respondents (36%) describing anti-social 
behaviour (particularly drink and drug-related behaviour, 
crime and safety issues) as being the worst thing about 
Dublin. There were over 400 mentions of drugs and drug 
use in the open responses. An initiative of Dublin City 
Council, in collaboration with the Dublin Regional Authority 
and the other Dublin local authorities, panel members 
will be invited to participate in regular ongoing surveys. 
www.yourdublinyourvoice.ie or www.facebook.com/
yourdublinyourvoice 
On 3 May 2011 the New Zealand Law Commission 
published its report Controlling and regulating drugs – a 
review of the Misuse of Drugs Act 1975. Among the key 
proposals contained in the report are (1) a mandatory 
cautioning scheme for all personal possession and use 
offences that come to the attention of the police, removing 
minor drug offenders from the criminal justice system 
and providing greater opportunities for those in need of 
treatment to access it; (2) a review of the current drug 
classifi cation system in order to address inconsistencies and 
to develop a system based solely on assessing a drug’s risk 
of harm, including social harm; and (3) making separate 
funding available for the treatment of offenders through 
the justice sector, in order to support courts when they 
impose rehabilitative sentences to address alcohol and drug 
dependence problems. www.lawcom.govt.nz 
On 4 May 2011 Europol published Organised crime threat 
assessment 2011 (OCTA), its bi–annual report assessing 
current and expected trends in organised crime affecting the 
European Union. It contains eight pages on drugs, including 
sections on heroin, cocaine, synthetic drugs, cannabis 
and qat. Drug crime groups are described as becoming 
increasingly ‘multi-commodity’ and ‘poly-criminal’, for 
example, dealing in more than one type of drug, engaging 
in other criminal activities such as producing counterfeit, 
co-operating with other groups in sharing loads or bartering 
drugs for other illicit goods such as stolen property and 
fi rearms. The benefi ts of such diversifi cation include greater 
resilience in face of drug market fl uctuations, less visibility 
and consequently less risk of detection, and greater profi ts. 
www.europol.europa.eu 
Compiled by Brigid Pike
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Recent publications
Books
Books recently acquired by the National Documentation 
Centre on Drug Use. 
Understanding Limerick: social exclusion and 
change
Edited by Niamh Hourigan 
Cork University Press (2011); ISBN 978-
185918-457-8 
www.drugsandalcohol.ie/15274
Drugs and culture: knowledge, consumption 
and policy
edited by Geoffrey Hunt, Maitena Milhet 
and Henri Bergeron
Ashgate (2011); ISBN 978-140940-543-6 
www.drugsandalcohol.ie/15302
Journal articles
The following abstracts are cited from recently published 
articles relating to the drugs situation in Ireland.
Acute liver failure following recreational use of psychotropic 
‘‘head shop’’ compounds 
Fröhlich S, Lambe E and O'Dea J 
Irish Journal of Medical Science, 2011; 180(1): 263–264
www.drugsandalcohol.ie/15368
This report describes the case of a 28-year-old male with 
bipolar affective disorder but otherwise healthy who 
presented with acute psychosis and subsequent hepatic 
failure following ingestion of butylone (a phenethylamine 
derivative) and methylenedioxypyrovalerone (MDPV, a 
noradrenaline and dopamine reuptake inhibitor). This is the 
fi rst case report associating these compounds with acute 
liver failure.
The great Irish head shop controversy
Ryall G and Butler S 
Drugs: education, prevention and policy, 2011; 18(4): 
303–311
www.drugsandalcohol.ie/15360
This research describes and analyses recent policy 
developments in Ireland in relation to the practice of selling 
psychoactive substances which, while not themselves illegal, 
mimic the effects of commonly used illegal drugs. These 
so-called ‘legal highs’ had been sold in Ireland through 
an increasing number of ‘head shops’ which in late-2009 
and early-2010 became the subject of considerable public 
controversy, culminating in legislative measures aimed at 
their closure. Based on semi-structured interviews with 
some of the main stakeholders in this process and set 
against a background of saturation media coverage of this 
phenomenon, this article presents and assesses competing 
perspectives on the head shop issue. From a conventional 
drug control perspective, recent legislative measures in 
Ireland may be seen as representing effective cross-cutting 
activity between the health and criminal justice sectors. From 
a harm reduction perspective, however, this policy response 
may be seen as an example of moral panic in that media 
portrayals greatly exaggerated the ill effects of head shop 
products, in the process stoking public anger rather than 
encouraging rational debate.
Anxiety and depression among opiate users who misuse 
substances during treatment 
Stapleton R and Comiskey C 
Irish Journal of Psychological Medicine, 2011; 28(1): 6–12
www.drugsandalcohol.ie/14869
This paper sought to describe and model anxiety and 
depression outcomes during opiate substance misuse 
treatment. This was the fi rst national, longitudinal treatment 
outcome study of 404 opiate users entering a new episode 
of inpatient or outpatient treatment and followed up at one 
and three years and assessed using the Maudsley Addiction 
Profi le instrument.
A total of 404 opiate users were recruited, representing 
approximately 8.2% of all new treatments and 17% of all 
new methadone treatments in Ireland in 2003. At three years 
97% (392) were followed up. At one year, analysis revealed 
the odds of experiencing depression was between fi ve and 
15 times the odds for opiate users who also used cocaine 
than non-cocaine using opiate users, but this had decreased 
at three years. At three years those who were drug free, that 
is, not in treatment and not using illicit drugs, were less likely 
to experience feeling hopeless about the future than those in 
treatment or those not in treatment and using illicit drugs, 
but they were also more likely to experience feeling tense. 
Those in treatment were more likely to feel lonely.
The concurrent misuse of cocaine and other substances 
during opiate treatment and the stage of the treatment 
pathway are associated with anxiety and depression among 
opiate users in treatment. These client factors need to be 
considered when implementing individualised treatment 
care plans.
A new mixed mode solid phase extraction strategy for 
opioids, cocaines, amphetamines and adulterants in human 
blood with hybrid liquid chromatography tandem mass 
spectrometry detection 
Dowling G and Regan L 
Journal of Pharmaceutical and Biomedical Analysis, 2001; 
54(5): 1136–1145 
www.ncbi.nlm.nih.gov/pubmed/21194869
A rapid method has been developed to analyse 
morphine, codeine, 6-monoacetylmorphine, cocaine, 
benzoylecgonine, dihydrocodeine, cocaethylene, 
3,4-methylenedioxyamphetamine, ketamine, 
3,4-methylenedioxymethamphetamine, pseudoephedrine, 
lignocaine, benzylpiperazine, methamphetamine, 
amphetamine, methadone, phenethylamine and levamisole 
in human blood. 
Blood samples were cleaned up using mixed mode solid 
phase extraction using Evolute™ CX solid phase extraction 
cartridges and the sample aliquots were analysed by hybrid 
triple quadrupole linear ion trap (QTRAP) mass spectrometry 
with a runtime of 12.5 min. Multiple reaction monitoring 
(MRM) as survey scan and an enhanced production (EPI) 
scan as dependent scan were performed in an information-
dependent acquisition (IDA) experiment. Finally, drug 
identifi cation and confi rmation was carried out by library 
search with a developed in-house MS/MS library based on 
EPI spectra at a collision energy spread of 35 ± 15 in positive 
mode and MRM ratios. 
drugnet 
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The method was validated in blood, according to the criteria 
defi ned in Commission Decision 2002/657/EC. At least 
two MRM transitions for each substance were monitored in 
addition to EPI spectra. Deuterated analogues of analytes 
were used as internal standards for quantitation where 
possible. The method proved to be simple and time effi cient 
and was implemented as an analytical strategy for the illicit 
drug monitoring of opioids, cocaines, amphetamines and 
adulterants in forensic cases of crime offenders, abusers or 
victims in the Republic of Ireland.
Prevalence of oral mucosal abnormalities in addiction 
treatment centre residents in Southern Ireland
O'Sullivan EM 
Oral Oncology, 2011; Epub ahead of print 
The study examined the prevalence of oral mucosal 
lesions and conditions among addiction treatment centre 
residents in southern Ireland and explored the feasibility and 
acceptability of a targeted oral cancer screening programme 
for such individuals. 
Four alcohol addiction treatment centres were visited 
periodically over a 12-month period. Two hundred and 
twenty residents (78% of 283 targeted) were interviewed 
regarding their alcohol, tobacco and drug habits 
(type, quantity, duration), and attitudes to dental care. 
Comprehensive oral examinations were performed. All 
potentially sinister soft tissue lesions or symptoms were 
referred for further investigation. Ten participants who 
said that they did not have a history of alcohol or other 
drug addiction were excluded from the main study. The 
remaining 210 participants comprised 148 males (70%) 
and 62 females (30%), ranging from 18 to 73 years of 
age; 60% were under 40 years. High rates of tobacco 
and alcohol usage were recorded, 53% reported dual 
addiction (alcohol and another drug), 44% alcohol only, 
3% drug only. The prevalence of mucosal abnormalities 
was 29% with 84 mucosal abnormalities or symptoms 
detected in 61 subjects, comprising 28 extra-oral lesions or 
symptoms and 56 intra-oral lesions. Residents with mucosal 
abnormalities were older (average 41.8 years; SD 14.3) 
than those without such lesions (mean 36 years; S.D. 13.3), 
(p<0.05). The most common oral mucosal abnormality was 
candidiasis or oral thrush (3.8%), followed by facial scaring 
or laceration (3.8%), intra-oral lumps or swellings (2.9%), 
lymphadenopathy (2.9%) and hoarseness (1.9%). Four red 
areas suggestive of erythroplasia and two leukoplakic lesions 
were detected. 
The study addresses the paucity of data on the prevalence of 
oral mucosal lesions in addicted persons in Southern Ireland. 
Despite the relatively poor follow-up compliance rate (33%), 
two premalignant lesions were confi rmed in the main study 
group, yielding a detection rate of 0.9%. Inclusion of oral 
cancer screening in the routine medical examination given 
to residents of addiction treatment centres may provide an 
effi cient and effective way to detect potentially malignant 
lesions in these high-risk individuals.
Recent publications  (continued)
Upcoming events
(Compiled by Joan Moore – jmoore@hrb.ie)
September
19 September 2011
Making progress in dual diagnosis – refocusing and re-
energising service improvement for the next decade
Venue: ORT House Conference Centre, London NW1 
Organised by / Contact: Pavilion, in partnership with 
Progress 
Email: info@pavpub.com 
www.pavpub.com
Information: This conference will focus on developments 
in service delivery and integration of treatment for people 
with a dual diagnosis of mental health and co-existing 
substance misuse,.with the aim of sharing new techniques 
and identifying future direction. Key speakers will include 
David Burrowes MP, Prof. Christine Barrowclough and Prof. 
Charlie Brooker. 
21–22 September 2011
The future of harm reduction and drug prevention in the UK
Venue: Glasgow/Edinburgh 
Organised by / Contact: Addiction Debates 
Email: Christopher at chris@addictiondebates.com 
http://addictiondebates.com
Information: Prof. Stanton Peele and Prof. Neil McKeganey 
will meet in Glasgow and Edinburgh on September 21st 
and 22nd, 2011, to debate the future of the harm reduction 
and prevention approaches to drug policy and treatment in 
the UK. These debates will be moderated by Mike Ashton 
(Editor of Drug & Alcohol Findings) and Dr Roy Robertson 
(University of Edinburgh). Issues that will be debated 
include:
• The individual and community health impact of 
harm reduction strategies
• Drug prevention strategies aimed at reducing supply 
and demand
• Drug criminalisation, decriminalisation, legalisation, 
and regulation
• Abstinence-based drug and alcohol treatment 
programs
• Methadone maintenance, needle exchange, and safe 
injection sites
• The policy implications of treating addiction as a 
brain disease
October 
8 October 2011
Parish prevention of substance misuse 
Venue: Clonliffe College, Drumcondra, Dublin 3 
Organised by / Contact: Crosscare Drug & Alcohol 
Programme and the Irish Bishops Drugs Initiative 
Tel: (01) 836 0911 
Email: info@crosscare.ie 
www.crosscare.ie
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Health Research Board
Knockmaun House
42–47 Lower Mount Street
Dublin 2
Tel: + 353 1 2345 148
Email: drugnet@hrb.ie
Managing editor: 
Brian Galvin
Editor: Joan Moore
Information: The aims of this conference are to 
show positive and simple ways in which a parish 
can play a part in prevention and awareness 
of drug and alcohol misuse, and to highlight 
supports available to parishes within the Dublin 
Diocese in relation to education and training. 
Booking is essential as places are limited. 
18 October 2011
Achieving a Rehabilitation Revolution – a 
national policy conference 
Venue: London
Organised by / Contact: Policy 
Communications
Email: info@policycommunications.co.uk
www.policycommunications.co.uk/conferences.
html
Information: This one-day policy conference, 
supported by the Probation Association, will 
explore the coalition government's reforms to 
the criminal justice system — examining plans 
for changes to the sentencing framework, how 
the 'rehabilitation revolution' aims to transform 
punishment and reduce reoffending, and how 
decentralising control and applying new models 
of commissioning will work in practice. 
November
2 November 2011
Delivering drug and alcohol services: Rising to 
the challenge
Venue: London N1 9RL
Organised by / Contact: DrugScope
Email: conferences@drugscope.org.uk
www.drugscope.org.uk
The sheer weight and speed of government 
activity which will directly or indirectly impact 
on our sector has left many breathless and not 
a little bewildered. There is the drug strategy 
itself, the localism and recovery agendas, 
welfare and NHS reforms, payment by results, 
election of police commissioners, the formation 
of Public Health England, the list goes on. This 
conference is an opportunity to step back and 
take stock of all these developments in the 
company of distinguished speakers, workshop 
leaders and panelists – your chance to debate 
the issues and share concerns with colleagues 
from across the UK.
3–4 November 2011
Drug Interventions: What Works? National 
Drugs Conference of Ireland 2011 
Venue: Radisson Blu Royal Hotel Dublin 8 
Organised by / Contact: Conference Steering 
Group /Irish Needle Exchange Forum 
Email: tim@inef.ie
http://inef.ie
Information: This year’s conference will build 
on the success of the 2010 conference, bringing 
together a range of national and international 
speakers from across the spectrum of addiction 
research, service provision and policy. The 
conference is sponsored by the HSE’s National 
Addiction Training Programme (NATP), 
which ‘welcomes this joint working with the 
Conference Steering Group, (representatives 
from the Irish Needle Exchange Forum, Ana 
Liffey Drug Project, Coolmine Therapeutic 
Community and the Irish Association of Alcohol 
and Addiction Counsellors)’ 
Confi rmed speakers include:
Mr Joao Goulao – Drug policies in Portugal: was 
decriminalisation helpful?
Thomas McLellan PhD – former deputy director 
of the US Offi ce of National Drug Control Policy, 
and founder and career researcher for 35 years 
with the Treatment Research Institute
Dr Andrew Tatarsky has specialised in the fi eld 
of substance use treatment for over 30 years as 
a psychologist, supervisor, program director, 
lecturer and author.
Dr Paolo Deluca – How the Internet and social 
media are driving the legal highs phenomenon: 
fi ndings from the ReDNet project
Mr Greg Purvis – If you build it they will 
come but if you don’t sustain it they will leave: 
implementing and sustaining evidence-based 
practice
Mr Martin Woods has worked in the anti-
money laundering space since 1984 when the 
fi rst drug traffi cking legislation was introduced 
in the UK.
Mr Brian Dalton has worked in health and 
social care for 13 years managing services across 
a variety of treatment sectors. 
Mr Martin Brown has worked in drug and 
alcohol treatment in London for over 25 years.
Upcoming events  (continued)
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